Agency of the United States Department of Health and Human Services
POPULARITY
Categories
469 episodes with fda
421 episodes with fda
300 episodes with fda
401 episodes with fda
208 episodes with fda
256 episodes with fda
145 episodes with fda
195 episodes with fda
195 episodes with fda
131 episodes with fda
107 episodes with fda
73 episodes with fda
199 episodes with fda
55 episodes with fda
84 episodes with fda
85 episodes with fda
72 episodes with fda
75 episodes with fda
143 episodes with fda
94 episodes with fda
66 episodes with fda
68 episodes with fda
135 episodes with fda
150 episodes with fda
111 episodes with fda
247 episodes with fda
61 episodes with fda
77 episodes with fda
52 episodes with fda
37 episodes with fda
104 episodes with fda
47 episodes with fda
47 episodes with fda
121 episodes with fda
100 episodes with fda
97 episodes with fda
73 episodes with fda
95 episodes with fda
73 episodes with fda
71 episodes with fda
50 episodes with fda
66 episodes with fda
44 episodes with fda
45 episodes with fda
53 episodes with fda
50 episodes with fda
69 episodes with fda
67 episodes with fda
85 episodes with fda
66 episodes with fda
38 episodes with fda
57 episodes with fda
54 episodes with fda
99 episodes with fda
Check out host Bidemi Ologunde's new show: The Work Ethic Podcast, available on Spotify and Apple Podcasts.Email: bidemiologunde@gmail.comIn this episode, host Bidemi Ologunde explores the rapid rise of prediction and betting markets, and why more people are suddenly treating odds as a serious signal about the future. What is driving their mainstream adoption now? Why are platforms moving beyond sports into politics, economics, and war-risk speculation? And when markets start pricing everything from championship games to the possibility of conflict with Iran, are they revealing collective intelligence, or just turning uncertainty into entertainment?Sponsors and partners:Promeed: 100% mulberry silk pillowcases and bedding that feel incredibly soft, stay breathable, and are naturally gentle on hair and skin.SurviveX: professional-grade FSA/HSA eligible first aid and preparedness kits designed in Virginia, USA and produced in an FDA-registered facility.Alison US CA: Alison is the world's largest free online learning and skills-training platform, helping more than 50 million learners in 193+ countries build career-ready skills with 6,000+ free courses, certificates, and diplomas.eSign (iOS only): eSign is a clean, privacy-first document-signing app that works entirely on your device, letting you sign PDFs, DOCX files, images, and scans, edit and assemble pages, and export crisp 300 DPI PDFs in seconds, without accounts, cloud uploads, or compromising sensitive documents.Support the show
On this episode of Vitality Radio, Jared sits down with Maggie Frank of CV Sciences to unpack the growing federal threat to hemp-derived CBD and low-dose THC products. With potential legislation that could dramatically restrict access as early as November 2026, this conversation explores what's at stake for consumers, retailers, and the natural health community. You'll learn what the proposed changes could mean for over-the-counter CBD products, and why responsible regulation—not prohibition—is the path forward. Jared and Maggie also discuss the importance of consumer education, the role of the endocannabinoid system, and how adults can make informed choices about plant-based wellness options. If you care about supplement freedom, access to hemp products, and protecting natural health choices, this is an episode you won't want to miss.Products:CBD Products - Visit Vitality Nutrition in Bountiful, Utah or call us to order 801-292-6662Additional Information:U.S. Hemp RoundtableVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
In this groundbreaking episode of the Tick Boot Camp Podcast, we interview Dr. Jayakumar Rajadas, a Stanford Medicine researcher who has discovered multiple breakthrough therapeutic candidates for Lyme disease, Babesia, and Bartonella. His work includes the discovery of Disulfiram's effectiveness against Lyme and Babesia, Azlocillin's potent activity against Lyme and Bartonella, and advanced targeted drug-delivery systems designed to preserve the gut microbiome. Dr. Jay's research has been featured in TIME Magazine (Azlocillin) and Forbes (Disulfiram), and connects deeply with the work of leading Lyme researchers, including Dr. Monica Embers (Tulane), Dr. Kim Lewis (Northeastern), Dr. Kenneth Liegner, and Dr. Brian Fallon (Columbia University). This interview delivers hope, science, and unprecedented detail on what may become the next generation of Lyme disease treatments. Key Topics Covered 1. How the Stanford Tick Initiative Sparked a New Era of Drug Discovery In 2012, Stanford launched a major initiative in response to community demand for better Lyme treatments. Dr. Rajadas was selected to lead drug development, focusing specifically on persistent/chronic Lyme disease, where few researchers were working. 2. Understanding Borrelia: Active vs. Stationary Forms & Why Chronic Lyme Persists Dr. J explains the three key survival modes of Borrelia burgdorferi: Active Phase The bacteria are replicating and metabolically active. Easier to kill with standard antibiotics. Stationary Phase Bacteria reach population limits and slow down growth. Represents early persistence mechanisms. Persister Forms Triggered by stressors like antibiotics (e.g., doxycycline). Bacteria fold into round bodies, spiral forms, or compact “cement-like” protective balls. These forms: Shut down metabolic pathways Resist penetration Survive antibiotic exposure Why Doxycycline Can Fail Doxycycline can induce persisters, causing Borrelia to form impenetrable protective shells rather than die. This is why many patients initially feel better, then relapse. 3. Disulfiram (Antabuse): Lyme + Babesia Breakthrough Featured in Forbes One of the biggest scientific shocks of the last decade: Discovery Through Stanford's high-throughput screening of FDA-approved drugs, Disulfiram emerged as a top hit. Clears Borrelia (including persistent forms) Clears Babesia — a major advantage over standard antibiotics Does NOT harm the gut microbiome Is already FDA-approved and widely used for alcohol aversion therapy Highly potent but requires careful dosing due to side effects in inflamed patients. Why Some Patients Improve, and Others Suffer Chronic Lyme patients already have heightened inflammation. Disulfiram is a powerful molecule whose polymorphic forms behave differently in different people. His lab developed: Less toxic formulations Buccal & sublingual delivery systems Rectal delivery options These may reduce neuropsychiatric side effects reported by some patients. Clinical Connections Dr. Kenneth Liegner pioneered clinical use and published cases Dr. Brian Fallon conducted NIH-listed clinical trials. Many clinicians now use Liegner's protocols. Real-world example: Matt shares the story of Brooke Stoddard (Generation Lyme), who regained his life after Disulfiram treatment under Dr. Liegner. 4. Azlocillin: The Antibiotic That TIME Magazine Called a Gamechanger If Disulfiram is the Lyme and Babesia weapon, Azlocillin may be the frontline tool for Lyme and Bartonella. Why Azlocillin Is Revolutionary Eradicates both active and persister forms of Borrelia. Destroys doxycycline-induced “cement ball” persisters by drilling into their vulnerable cell-wall synthesis pathways. Proven effective against Bartonella when paired with azithromycin, based on research by Dr. Monica Embers (Tulane) . The Cell-Wall Vulnerability Breakthrough Persisters STILL must maintain minimal cell-wall synthesis to survive. Azlocillin exploits this tiny vulnerability: It penetrates the protective sphere Breaks the “cement wall” Forces the bacteria out of hibernation Kills them rapidly This discovery is one of the biggest scientific leaps in Lyme research in a decade. The Delivery System That Protects the Gut Microbiome Azlocillin is extremely hydrophilic, making absorption difficult.Dr. Jay fixed this by creating: A magnesium-lipid nanoparticle formulation Designed to release in the upper intestine Avoiding the colon (where most microbiome lives) This allows: High bloodstream absorption Minimal microbiome damage Oral availability of a drug previously only available via IV Why Azlocillin May Be Better Than Disulfiram Hits Borrelia + Bartonella Stronger anti-inflammatory effects No polymorphism issues Fewer side effects Potent against persisters A company is preparing to bring his oral formulation to clinical trials by next year. 5. Loratadine (Claritin): The First Clue from 2012 Before Disulfiram and Azlocillin, Dr. Jay's lab identified Loratadine (Claritin) as a manganese transporter inhibitor of Borrelia. Why it mattered: Borrelia uniquely relies on manganese, not iron. Blocking manganese uptake may weaken the bacteria. The discovery went viral, with many patients reporting improvement even at OTC doses—though the binding affinity was weak. This project introduced the concept of drug repurposing for Lyme to the scientific community. 6. Melittin (Bee Venom) — The Micro-Needle Patch Alternative Bee venom therapy is widely used in the Lyme community, but risks stings and allergic reactions. Dr. J is developing: Melittin micro-needle patches Delivering the active peptide without stinging Using dissolvable, painless needles A safe, controlled, pharmaceutical-grade delivery approach This could modernize bee venom therapy and make it more accessible. 7. Mechanism of Brain Fog & Fatigue in Lyme: A Major Breakthrough Dr. Jay's lab published a neuroscience paper demonstrating: Outer Surface Protein (Osp) Nanoparticles Borrelia sheds lipid-coated outer membrane particles. These form stable nano-vesicles that: Enter the bloodstream Cross into the brain Cause mitochondrial dysfunction Reduce ATP production Result: Brain Fog, Fatigue, Cognitive Dysfunction This explains why neurological Lyme can persist even after bacterial levels drop. This work ties strongly to ongoing research at Columbia University under Dr. Brian Fallon. 8. Collaborations With World Leaders in Lyme Research Dr. J's research intersects with: Dr. Kim Lewis (Northeastern University) Reproduced and validated Disulfiram findings publicly. Helped launch interest in persister-killing therapies. Dr. Monica Embers (Tulane University) Demonstrated Azlocillin + Azithromycin effectiveness against Bartonella. One of the world's foremost experts in persistent infection models. Dr. Kenneth Liegner Early clinical pioneer of Disulfiram therapy. Published stunning recovery cases. Dr. Brian A. Fallon (Columbia University) Leading psychiatrist specializing in post-treatment Lyme. Conducted planned Disulfiram clinical trials. These collaborations form a powerful network accelerating treatment development. 9. New Anti-Inflammatory Discoveries: Galangin & More Dr. Jay recently co-authored a 2025 paper on: Galangin (Thai ginger rhizome extract) Which may reverse cardiac inflammation and fibrosis His team is also exploring other nutraceutical molecules for chronic inflammation relief in Lyme patients. 10. Dr. Jay's Personal Story of Illness and Hope He reveals for the first time: He was diagnosed with Stage 3 Multiple Myeloma Lost the ability to walk Suffered unbearable pain After cutting-edge therapies and research, he is now in full remission His message to Lyme patients: “There is ALWAYS hope.”
U.S. President says Iran will be hit hard on Saturday, as he weighs new targets. One week into the Iran war, the risks for the U.S. and the administration multiply. Tehran apologizes to its Gulf neighbors but strikes escalate. Hundreds of thousands flee Israeli bombs in Beirut. Russian President Vladimir Putin calls for an immediate end to the Iran war. And the FDA vaccines chief will step down in April. Plus, Formula One enters a new era. Listen to the Morning Bid podcast here. Sign up for the Reuters Econ World newsletter here. Listen to the Reuters Econ World podcast here. Find the Recommended Read here. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt out of targeted advertising. Learn more about your ad choices. Visit megaphone.fm/adchoices
In episode 2018, Jack and Miles are joined by comedian and host of Abolish Everything, Chandler Dean, to discuss… Noem’s TERRIBLE Week, RFK Jr vs Dunkin, You Can Blame Big Oil and Big Golf For Daylight Saving Time and more! Tillis to Noem: "Those are bad decisions made in the heat of the moment, not unlike what happened in Minneapolis." Rep. Kamlager-Dove enters articles in the congressional record with headlines like, "Lewandowski taking out trash at Noem's DC home" and "ICE Barbie's mile high private chamber with alleged lover exposed" Noem Gets Grilled Over Government Contracts RFK Jr vs Dunkin RFK Jr. took aim at Dunkin'. Mass. residents threatened revolts Your favorite iced summer coffee could contain 46 teaspoons of sugar — the same as drinking 5 cans of Coke British Columbia Will Change Clocks on Sunday for the Last Time 7 Things to Know About Daylight Saving Time The dark side of daylight saving time B.C.'s premier is celebrating the move to permanent daylight time. Others aren't so sure Bill To Make Daylight Saving Time Permanent Stalls In Congress Again What Happened the Last Time the U.S. Tried to Make Daylight Saving Time Permanent? The Real Reason Why Daylight Saving Time Is a Thing The stakeholders of daylight saving time Golf industry tees up fight to keep daylight saving time The business of Daylight Saving Time, from golf to oil 9 Things You Probably Don't Know About Daylight Saving Time The Reasoning Behind Changing Daylight-Saving Is permanent daylight saving time a good idea? Lobbyists, lawmakers and sleep experts are split. What would ‘half-daylight saving time’ look like? LISTEN: Mesa Mesa by YuufSee omnystudio.com/listener for privacy information.
This hidden ingredient in junk food is quietly destroying your health. Uncover the harmful food additives and food industry secrets that leave you sick, yet still hungry for more. Learn how these hidden junk food ingredients sabotage your gut health and how you can avoid them starting today.Download Dr. Berg's Free Daily Health Routine: https://drbrg.co/45qtO07This dangerous ingredient in junk food acts as a detergent in your gut. This toxic food additive destroys the protective layer that lines your digestive tract, similar to the way dish soap removes grease from a pan. Once this protective layer is gone, you can develop a leaky gut, allowing toxic food additives, bacteria, and partially digested food into your bloodstream.Harmful food additives are often hiding in ice cream, chocolate, salad dressing, plant-based milk, bread, peanut butter, coffee creamer, mayo, baby formula, and the list goes on! This toxic ingredient is found in 60% of all packaged foods, and goes by names like polysorbate 80, carboxymethylcellulose, and carrageenan. These hidden ingredients in junk food are called emulsifiers. Emulsifiers force oil and water to mix so that the processed food appears smoother or creamy in texture and has a longer shelf life. There is a thick layer of mucus that coats the inside of the intestines, which acts as a built-in protective mechanism for your gut. Emulsifiers dissolve this protective layer over time, allowing bacteria to enter your bloodstream. Your immune system tags them as pathogens, causing an immune reaction and chronic gut inflammation. Gut health directly affects your cognitive function. If you have gut inflammation, you might experience brain fog, sluggishness, and the inability to think clearly after eating. In animal studies, polysorbate 80 caused metabolic syndrome, weight gain, blood sugar problems, and altered gut bacteria. Although no long-term human studies have been published, a human trial published in 2024 found that participants had altered gut microbiomes after just 2 weeks of eating emulsifiers. In the US, food additives can be self-classified as generally recognized as safe (GRAS). Junk food companies do not have to submit long-term human trials to the FDA. The easy solution to this problem is to avoid ultra-processed foods. Instead of focusing on willpower and discipline, avoid buying junk foods altogether. Dr. Eric Berg DC Bio:Dr. Berg, age 60, is a chiropractor who specializes in Healthy Ketosis & Intermittent Fasting. He is the Director of Dr. Berg Nutritionals and author of the best-selling book The Healthy Keto Plan. He no longer practices, but focuses on health education through social media.Disclaimer: Dr. Eric Berg received his Doctor of Chiropractic degree from Palmer College of Chiropractic in 1988. His use of “doctor” or “Dr.” in relation to himself solely refers to that degree. Dr. Berg is a licensed chiropractor in Virginia, California, and Louisiana, but he no longer practices chiropractic in any state and does not see patients, so he can focus on educating people as a full-time activity, yet he maintains an active license. This video is for general informational purposes only. It should not be used to self-diagnose, and it is not a substitute for a medical exam, cure, treatment, diagnosis, prescription, or recommendation. It does not create a doctor-patient relationship between Dr. Berg and you. You should not make any change in your health regimen or diet before first consulting a physician and obtaining a medical exam, diagnosis, and recommendation. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.
What happens when one of the most disciplined bodies in the world can't do the one thing everyone assumes it should? On this episode -- one of our most downloaded of all time -- Ali sits down with Mathilde Froustey, principal dancer at the San Francisco Ballet and widely considered one of the most extraordinary dancers in the world.Born in Bordeaux, France, Mathilde began dancing at just nine years old, training at the prestigious Marseille National School of Ballet and the Paris Opera Ballet School before rising to the top of the international ballet world. Onstage, her body is her instrument — powerful, precise, and seemingly unstoppable. But behind the curtain, Mathilde has been fighting battles that almost no one in the dance world talks about. In this candid and emotional conversation, she opens up for the first time about her experience with infertility — a subject she says remains deeply taboo in professional dance. Mathilde shares what it was like to go through IVF while performing at the highest level, navigating intense body scrutiny, and hearing painful comments about her appearance during one of the most vulnerable periods of her life. She also talks about her past struggle with an eating disorder, the pressure dancers face to maintain a certain body type, and the silent toll of trying to build a family inside a culture that rarely makes space for it.“In the dance world, infertility is a taboo subject,” Mathilde says.Not anymore.This is a powerful conversation about perfection, pressure, and what it means to reclaim your body — both onstage and off.EPISODE SPONSORS: THE WORK OF ART BOOK SERIESAli's Children's Book Series about IVF, IUI and Family Building Through Assisted Reproductive Technology https://www.infertileafgroup.com/booksThe 3-book bundle is now just $49 (normally $79)!The latest book in the Work of ART series, “You Are a Work of ART," is for every kiddo born through ART -- and the people who love them.PHERDALIG: @pherdal_sciencePherDal is the world's first and only FDA-cleared, sterile, at-home insemination kit designed to help people build their families in the comfort of home. Created by parents who've been there, PherDal is safe, simple, and affordable—putting more options in your hands as you grow your family. Explore at PherDal.com.Go to PherDal.com today and use code INFERTILEAF for $10 off.BELIIG: @belibabywww.belibaby.com Are you thinking about growing your family? Whether you're just starting to plan or are actively trying to conceive, preconception health is key. Beli has vitamins to help both women and men optimize their health before pregnancy. With essential nutrients like Folate, Iodine, and Zinc, Beli ensures your body is ready for this exciting next step. Give yourself and your future baby the best foundation for a healthy start.Visit Belibaby.com today and use code IAF15 for 15% off your first order. Our Sponsors:* Sign up and get 10% off at BetterHelp dot com. Your emotional wellbeing matters. Find support and feel lighter in therapy. Support this podcast at — https://redcircle.com/infertile-af-infertility-and-modern-family-building-through-art/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
uniQure is a business that develops gene therapies. uniQure's AMT-130 is currently in the headlines. This podcast episode attempts to present the Huntington's Disease community's arguments for why the FDA should work collaboratively to design a palatable drug trial. Last week the FDA told uniQure that AMT-130 would be subject to a double blind, Phase 3, randomized controlled study. While the scientific basis for that request is sound in most cases, the Huntington's Disease community argues that path is overly burdensome; perhaps impossible. This episode cites:Dr. Sung - https://www.youtube.com/watch?si=VhMQaFAZRvQA5NRj&t=62&v=mwEEJ91LeJY&feature=youtu.beSr. Sarah Tabrizi - https://www.youtube.com/watch?v=wKj1JRfJBRE&t=356sDr. Ed Wild - https://www.spreaker.com/episode/uniqure-update-with-dr-ed-wild--67900959FDA papers - External Control Guidance https://www.fda.gov/media/122425/downloadUse of Bayesian Statistics - https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-bayesian-methodology-clinical-trials-drug-and-biological-productsSenate Committee on Aging - https://www.youtube.com/watch?v=yLm1SltbRxw&t=2702sSponsorship InformationThank you to Trata for sponsoring the show.If you're listening to this podcast, you'll like Trata. Trata is buyside to buyside conversations on individual stocks. Trata makes finding a bull or bear on any stock as easy as clicking two buttons. Over 125 funds globally contribute that collectively cover 2000+ tickers. Trata raised over $3mm coming out of Y Combinator. Before you would track 13Fs, now you can understand what funds are actually thinking. You can join as a lurker or you can join as a contributor and Trata will pay you hundreds of dollars per call. For a free trial, go to trytrata.com/brew OG Sponsor Shoutout!Thank you to Fiscal.ai for sponsoring the show. DISCOUNT INFO: If you use the affiliate link fiscal.ai/brew, you will automatically get 2 weeks of Fiscal Pro for Free and if you find that you want to upgrade, my link will get you 15% off any paid plans. About Fiscal.aiFiscal.ai is the complete modern data terminal for global equities.The Fiscal.ai platform combines a powerful user experience with all the financial data capabilities that professional investors need. Users get up to 20 years of historical financials for all stocks globally that they can easily chart, compare, or export into their own models. And unlike legacy data terminals where it can take hours or even days, Fiscal.ai's data is updated within minutes of earnings reports. Fiscal.ai also tracks all the company-specific Segment & KPI data so you don't have to. Like to track Amazon's Cloud Revenue? They've got it.How about Spotify's premium subscribers? Or Google's quarterly paid clicks?They've got all of it.
Dr. Marc Pietropaoli is an orthopedic surgeon and founder of Victory In Motion, home of Knee Repair, NOT Knee Replacement®. A former fellow of Dr. James Andrews, he has spent more than 25 years advancing regenerative and non-operative orthopedic care. He was the first surgeon in the world to perform an FDA-indicated BEAR ACL repair outside of clinical trials. His mission is bold: make the world Knee Replacement Free by 2043. In this episode, Dr. Mark Pietropaoli shares how he went from traditional orthopedic surgery to pioneering regenerative approaches like stem cells, PRP, laser therapy, and his Victory Method to help people repair knees instead of getting knee replacements. RESOURCES: Learn more about Dr. Pietropaoli here: http://www.victoryinmotion.com Instagram: @drmarcpietropaoli Get his book "Repair Not Replace" here: https://amzn.to/4uclnk3 Get 10% off Peluva minimalist shoe with coupon code COACHTARA here: http://peluva.com/coachtara CHAPTERS: 00:00 – Intro 01:52 – Sponsor: Peluva minimalist shoe ad 03:47 – Dr. Pietropaoli's background 04:35 – Witnessing a knee replacement and asking "Isn't there a better way?" 09:12 – Training, indoctrination, and early exposure to regenerative tools (laser, PRP, PT, nutrition) 21:24 – Stem cells, aging joints, and why knees break down over time 48:51 – The Victory Method, clarity day, and full-body assessment process 53:19 – Testing, imaging, goal‑setting in one visit 53:57 – Virtual care, state licenses, and working with out‑of‑town patients 58:30 – Where to find Dr. Pietropaoli WORK WITH TARA: Are You Looking for Help on Your Wellness Journey? Here's how Tara can help you: TRY TARA'S APP FOR FREE: http://taragarrison.com/app INDIVIDUAL ONLINE COACHING: https://www.taragarrison.com/work-with-me CHECK OUT HIGHER RETREATS: https://www.taragarrison.com/retreats SOCIAL MEDIA: Instagram @coachtaragarrison TikTok @coachtaragarrison Facebook @coachtaragarrison Pinterest @coachtaragarrison INSIDE OUT HEALTH PODCAST SPECIAL OFFERS: ☑️ Upgraded Formulas Hair Test Kit Special Offer: https://bit.ly/3YdMn4Z ☑️ Upgraded Formulas - Get 15% OFF Everything with Coupon Code INSIDEOUT15: https://upgradedformulas.com/INSIDEOUT15 ☑️ Rep Provisions: Vote for the future of food with your dollar! And enjoy a 15% discount while you're at it with Coupon Code COACHTARA: https://bit.ly/3dD4ZSv If you loved this episode, please leave a review! Here's how to do it on Apple Podcasts: Go to Inside Out Health Podcast page: https://podcasts.apple.com/us/podcast/inside-out-health-with-coach-tara-garrison/id1468368093 Scroll down to the 'Ratings & Reviews' section. Tap 'Write a Review' (you may be prompted to log in with your Apple ID). Thank you!
Broadcast from KSQD, Santa Cruz on 3-05-2026: Dr. Dawn demonstrates how to critically read a science paper using a widely-publicized study claiming adolescent cannabis use causes psychotic, bipolar, and anxiety disorders. She identifies multiple methodological problems: only 5.7% of Kaiser adolescents admitted cannabis use versus 11.2% in anonymous national surveys, suggesting massive underreporting; the study conflates any use with heavy use; and with 463,000 participants, trivially small differences become statistically significant but clinically meaningless. She proposes reverse causation—that prodromal schizophrenia symptoms may drive teens to self-medicate with cannabis rather than cannabis causing psychosis. The study also included "disruptive behavior disorder" diagnoses that lack rigorous criteria, and she notes diagnostic codes are sometimes chosen for insurance reimbursement rather than accuracy. While acknowledging high-dose THC before age 16 may affect brain development, she concludes the headlines claiming causation are not supported by the actual findings. Dr. Dawn discusses how aquaculture—now producing 60% of fish consumed globally—has become a breeding ground for antibiotic-resistant pathogens. More antibiotics per kilogram are used in fish farming than in any other animal agriculture, with drugs dissolving into water and sediment where bacteria develop resistance. One study found antibiotic-resistant bacteria in over 80% of shrimp species tested across multiple countries. Through horizontal gene transfer, these resistance genes spread to human pathogens—a 1991 Latin American cholera outbreak affecting nearly a million people may have acquired drug resistance from Ecuadorian shrimp farms. Dr. Dawn reports that the FDA rejected Moderna's mRNA flu vaccine application without even reviewing it, despite trials of 41,000 people showing it was 27% more effective at preventing illness and 29% more effective at preventing hospitalization than existing vaccines. She attributes this to politicized anti-mRNA bias lacking scientific basis, noting that venture capital investors like Blackstone (who invested $750 million) will now avoid vaccine development, effectively handing this critical technology to other countries. Dr. Dawn describes the "wellness industrial complex"—pharmaceuticals, tech, testing companies, and health influencers creating content that pathologizes normal behaviors. YouTube health videos have amassed 200 billion views, and 30% of British respondents now get medical advice from AI chatbots. She cites a 400% increase in British adults seeking ADHD diagnoses, noting that analysis of top TikTok ADHD videos found less than 50% accurately reflected actual symptoms. Many influencers receive undisclosed payments to mention products, and the U.S. and New Zealand are the only countries allowing direct-to-consumer drug advertising. A caller asks about navigating Medicare after their Advantage plan was terminated with no local providers accepting remaining plans. Dr. Dawn explains that Medicare Advantage companies took extra government payments meant for wellness programs but didn't build them, and are now exiting markets as costs rise. She recommends contacting Gray Bears or AARP for free Medicare navigation assistance and suggests exploring regular Medicare with a secondary plan or direct-pay practices. /li>
Logan McKnight is the founder of GoodKnight Consulting and a strategic advisor to MedTech executives navigating growth, leadership challenges, and operational complexity. Logan shares her nearly 20-year journey from pre-med to neuromonitoring technologist to CEO, and explains why she now focuses on helping leaders build teams that scale without sacrificing culture or burning out. She discusses lessons learned managing remote surgical service teams, why “simple scales,” and how mission, vision, and values enable better decisions and hiring beyond gut instinct. Guest links: https://www.goodknightconsulting.net/ Charity supported: ASPCA Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com. PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical EPISODE TRANSCRIPT Episode 075 - Logan McKnight [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I am delighted to welcome Logan McKnight. Logan is the founder of GoodKnight Consulting and a strategic advisor to MedTech executives navigating growth, leadership challenges and operational complexity. With nearly 20 years in neuromonitoring and surgical services, including experience as a CEO, VP of Operations and business development leader, Logan brings an experienced perspective to executive leadership. She works with directors, VPs, and C-suite leaders to build teams that can scale without sacrificing culture or burning out. Well, welcome to the show, Logan. I'm so glad to speak with you today, and thank you so much for being here. [00:01:34] Logan McKnight: Yeah, it's great to be here. I appreciate you inviting me. [00:01:36] Lindsey Dinneen: Of course. I'd love if you wouldn't mind starting off by sharing just a little bit about yourself, your background, and what led you to MedTech. [00:01:45] Logan McKnight: Of course. Yeah. So my name is Logan McKnight and I have been in medtech for almost the last 20 years. And I think my journey, I, a lot of people have a very similar like origin story of haphazardly finding their way into medtech. I was pre-med in college. I wanted to go into veterinary school and I think I panicked honestly last minute, not really wanting to go. I interned under vet who basically dissuaded me from doing all the work of vet school and said go to med school. And feeling a little lost, I found my way to medtech, particularly neural monitoring, which was a field, pretty niche, but basically I got trained by a company to go in and run equipment and monitor patient's nervous systems during surgery. And to me, just having my bachelor's degree and having that level of impact and being able to jump right into patient care without having to go to more, you know, years and years of schooling was right up my alley and it's been such a wild ride. You know, I was a technologist and then I became a manager and then VP of development of business development, and head of contracting. And then I went over to a small company where I was the vice president of the whole company, and then eventually CEO, and now I'm consulting for medtech companies. So it's been a really fun journey that I didn't plan at all. [00:03:06] Lindsey Dinneen: Yeah. Okay. Well, excellent. And that brings up so many questions, but to start, so you were thinking originally you might wanna be a vet. Do you have you know, like, did you grow up with animals? Did you just have an amazing love for them? Where did that come from? [00:03:23] Logan McKnight: You know, honestly, I think I would've had way more animals, but my parents were a lot more reasonable than I was. So we just had the regular pets, but I grew up like horseback riding and in the Midwest, in Ohio. So I was around a lot of farm animals and things like that and I was part of like FFA and horticulture. So future Farmers of America. And I actually was really interested in large animals because I didn't wanna deal with people, I didn't wanna deal with people or their pets. So, and you know, and so that was what panicked me about med school was like the whole plan was veterinary school was to avoid the people part. And then I found through medtech you know, neuromonitoring and surgery where my patients are asleep. And so I still got to do all the things that I love, like providing impact, but then, you know, not having to worry about, I guess all for me I just had my head like all the challenges and complications that deal dealing with patients that I thought would make my job and life really difficult. So it's been really fun to kind of focus on just like the care and how to move things forward and explore this big, wide open space of how to impact people's lives in surgery. [00:04:31] Lindsey Dinneen: Yeah. And you know what's interesting about that too is, though, I think it sounds like throughout your, though, as you've, you know, gone from technologist and then you've had all of these amazing career changes and growth basically. It sounds like, you know, you have developed though your own kind of leadership style, so even though maybe originally you weren't sure about dealing with people, so to speak, you've actually excelled at it. So I'm curious how that has evolved for you in creating and managing teams. [00:05:03] Logan McKnight: Yeah. You know, it's interesting. I think like initially I was trying to control all these variables before I got into leadership in people, and then realized like you can't do that once you get to actually working with people. And once you almost like acknowledge and recognize, you can't control that but there's some beauty in that of you just allow for what you allow and then you know, you have to give people the ability to function like at their level. And you create the parameters. But other than that, like some magic happens when you don't try to control every single thing. And I see so many, especially new managers, you know, being like, "I need to control everything." And they're wondering why they're exhausted or their team's not respecting them. And it's like, gotta let go, gotta let go of the wheel a little bit. So, you know, I think those are some lessons and sometimes they just come with time and experience. [00:05:55] Lindsey Dinneen: Yeah, absolutely. Yeah. So, when you started, well, let's go back to the beg, maybe it's kind of at the beginning of your career. What are some things that you learned as a technologist and as you were growing within the hospital systems themselves, that contributed to basically where you would become now to become an entrepreneur and all of that. [00:06:21] Logan McKnight: Yeah, I mean, I will be very honest, and this is not meant to be a dig at anybody who I'd worked with or any boss. But I just, I went to work for a private company and we went and we were almost like hired mercenaries. So we would go to like, you know, every day I was in a different hospital. I didn't know my schedule till the night before. I rarely saw my manager and, you know, rarely saw other members of my team and it really felt like I was very isolated and alone. And it added to my burnout and also feeling like I didn't have anyone watch, like looking out for me and my back as a younger employee. And I realized there was so much room for improvement there in how you manage a team remotely. And so I think I, I just like mentally I was a psychology major before I switched to pre-med, and so I think like the, like human brain, because I was, you know, neuroscience, but like psychology, I think is so fascinating to me and the way people tick and what makes them tick. And I, I'm a big believer if you can figure out the way people tick, you can unlock so many things in the world and like you can, you know, you can be the most brilliant person, but if you can't communicate effectively, if you can't manage a team, you're really not gonna take things to the next level because you're not gonna activate those people around you to perform and get something done. So I feel like it was a case study for me to kind of watch like these managers and struggle and I'm like, "Ah, that's what I'm not going to do." [00:07:47] Lindsey Dinneen: Yes. Yeah. Sometimes learning from examples that maybe you wish you didn't have to learn from though can be the best teachers and actually serve your, you know, your own leadership style and your people that you end up getting to influence. It actually does help in the long term, but so. [00:08:06] Logan McKnight: Totally. [00:08:07] Lindsey Dinneen: So when you started GoodKnight Consulting, what was the impetus for that? I mean, you'd had this you've had this amazing career so far. You're ready kind of just for the next step or what sparked that? [00:08:19] Logan McKnight: You know, it's interesting, I stepped down from my CEO position 'cause I was feeling, I was running a neuromonitoring service company in the Pacific Northwest. We also had a professional services arm with neurologists. And then I had a medical billing company that I was running and we did mostly out of network billing. And then we also started a company in India right before COVID. So by 2023, I was fried, I was very burnt out in the way that I felt like I was busy all the time, but not really having the same impact I used to have. I think a lot of that was like I, I got more involved on the litigious side of running a company and then also the medical billing side really takes it out of you. So the thing I enjoyed was the coaching and the mentoring, and once I took a little bit of a step back and thought about what would I do every day for free? You know, like, what would I just love to do? And the reality was coaching other leaders, especially one like scratched my itch for helping people and provide and like, impact, which I realize is my biggest driver is like, how do I impact the most people and walk away with, you know, my life feeling like I've touched people in a positive way, and I think that's, you know, my, my driving force. So that's kind of why I started. And I started honestly just trying to go to leaders individually and offer some webinars and some one-on-one coaching. And then I really realized working with companies actually is the best way to go about this because you get ownership and leadership that's totally aligned and they want that support for their leaders. And then, it's so much easier to see the impact spread throughout an organization, so that's been really cool, is to be this outside force driving an owner or an executive's vision of what they want their company or the team to be. [00:10:07] Lindsey Dinneen: Yeah, and I noticed when I was reading a little bit more about the company, one of the things that I thought was really interesting is you talk about there, this is not just let's say leadership or mindset coaching or something like that, although that is very important as well. It is also about the business strategy. And you talk a lot about, you know, you've been in the position to understand how much, of course, revenue matters. You ha you have to, you know, make sure that's a strong, you know, foundation for the business. So, so how do you balance the two when you work with clients? [00:10:45] Logan McKnight: Yeah, no, that's a great question. I think every client is unique. I have found that just stripping away-- actually with something I, a blog post I was working on today and something I posted on LinkedIn, and it's something I find myself saying to founders and owner operators all the time-- simple scales. And I think, you know, what ends up happening is a lot of times you get this great idea for a product, a service, a company, and you just go. And you don't sometimes sit down and create like the true mission or the vision and like the values of the company. And it's really hard for owner operators and people who are in startup land and you know, small businesses to pause and do that, especially if they've been going for a few years 'cause you know, it's like, "Well, I've been operating without this stuff. It's totally fine." The reality is it's so much easier to grow and scale and also to gut check yourself when you're making decisions and being like "This is the right call because this aligns with our mission and our vision for the company or our growth initiatives for this year. And then it aligns with my values. I feel good about this decision and I can communicate it to people I hire. So I trust those people." And like that's what scales is, the trust and people having like the unified mission and vision and values and like, I know it sounds a little touchy feely, but the reality is like that's actually what I feel like I end up centering owners and operators on. It's less about the minutia and the details and more about like, does this make sense with where you wanna go and the way you, and the way you wanna get there. [00:12:21] Lindsey Dinneen: Yeah. Yeah, exactly. Okay. Yeah, I really like that. And with the emphasis on the unified team in terms of, you know, we don't all have to view life exactly the same, but we need to be aligned, at least with our mission and values and things like that. What do you find are some of the best practices when it comes to building out a team? And on the flip side, what are some things that maybe are common or that feel like they would be good practices, but in reality might not be. Like, what are some lessons learned, I suppose, on both sides? [00:12:56] Logan McKnight: Yeah. I mean, I think, I'll be honest, I think a lot of owners and maybe leaders who've been in their position for a while, like, like there-- I was talking to somebody else about this, about your gut feeling and like, go with your gut and trust me. I was a big go with my gut leader especially as a CEO, but like that doesn't scale because you have to be able to verbalize like, what are the things you're looking for? Why did you pick this person? And so at the end of the day you know, I had a policy when I was probably right, became, when I became a CEO that I needed to like approve after a couple not so great hires, I needed to approve every hire. And like the reality is that's not realistic, that's not gonna scale as you grow. And so I just needed to create the, this is what we're looking for like, you know, we're hiring for attitude. We can train the aptitude, we can train the technical depending on what the job is. But, you know, here's what we're really looking for, is a good fit for the company and the culture. And then, because once I had people who I knew really got that and saw the vision, I knew they were gonna make the right choices. And so I didn't feel like I had to. Be the one making that decision, I could scale it and help, you know, allow my team to hire for the people in the places that they needed and saw. [00:14:09] Lindsey Dinneen: Yeah. Okay. Yeah, I really like that. So, one thing that I thought was interesting, especially so on your LinkedIn profiles, I was, you know, enjoying reading more about you and some of the things you've done. But you had mentioned that sometimes there's a trade off between hitting targets and then you're burning out your team for the opposite. You're protecting your team, but then you're not hitting your targets. Could you speak a little bit more about that and how you help companies sort of overcome that challenge. [00:14:40] Logan McKnight: No, and I mean, I think it's like, I equate like, I think when I first became a leader, you know, talking about how my viewed my other leaders maybe know what not to do, I definitely swung the pendulum too far the other direction when I first started. And I was way too, I don't know, I was way too, all the things I didn't get. And so two, like checking in with my team, "How are you doing?" Not wanting to delegate work to them and doing these things because you know, and so I realized there's you, I think that's like an initial thing a lot of leaders go through is that shift. It's when you get stuck in the one extreme or the other and you don't really find your good at equilibrium, that it's really hard to sustain. And I think it's really important to find your equilibrium of, like, "This drives us to hit quota. This drives us to get our metrics and to for success. And then it does it in a sustainable way that our team's gonna stay." Because to me, like, sustainable. I kind of was thinking about my values even this morning and I'm like, I think fun is really one of my values like, I want to really enjoy like not just my personal life, but my professional life, and I think your job, your company, all of those things is a lot more fun when it's sustainable, right, when you're like exhausted. So finding a way for it to be sustainable for your team, for, you know, and everyone likes to win. Like it's fun to hit quota. It's fun to like crush your metrics and celebrate. So it, how do you know, make that sustainable and fun? And I think that's like a long-term success or recipe for success with a company. [00:16:15] Lindsey Dinneen: Yeah. Yeah. Well, and you know, it's so interesting 'cause actually this has come up a couple of times recently on the podcast is the sort of core value of fun and how much that does actually transform people's experience with the company. And you know, because inevitably you're gonna have those days that are just really tough and hard. And so being able to though have a culture of fun and joy is, it does make a difference. Yeah. [00:16:42] Logan McKnight: No, for sure. I remember when I first started working in surgery and someone asked me, they're like, "Oh, is it like Grey's Anatomy?" And, you know, and I'm like, "It's not nearly as like sexy. Like there's no, you know, doctors in closets and whatever." The, I, it's actually more like the show Scrubs and the reality is, and people are like, "Oh, that seems like goofy and comedy." I'm like, "I know." But the, I think the reality is we view in like healthcare and medtech of like this, you know, taking care of patients, a serious job. We're talking to surgeons. But for anybody who's really good at their job, like, you know, you see, especially in surgery in these high stakes environments, like it's actually the best rooms to be in are a lot of fun because you rely on your team, you know everyone's gonna do well, or you know their job well. If shit hits the fan, the tone changes and you can trust that. But I think because you trust your team. It's fun, you know, in more moments than not because there's just so much trust that when things get serious, people will speak up and it's safe. I think you like when you're psychologically safe, it's enjoyable, it's fun, and you also feel like you can speak up when you say something wrong. And I feel like those are the healthiest like work dynamics, both in healthcare then, especially in medtech when you're putting a product out there, like you want somebody to say something if they see a problem with your product before it goes to market, right? [00:18:05] Lindsey Dinneen: Well, and I love that. I love that perspective too of, you're absolutely right, healthcare, medical devices, it is it is serious by nature and it should be like, we should take our jobs seriously. But at the same times, if we could not maybe take ourselves as seriously and, you know, and infuse the fun and it does help also I think dissipate some of that-- well, some of the really hard, you know, again, those days that are tough it helps to be able to say, you know, take a step back and go, you know what, "It's yes, and." [00:18:37] Logan McKnight: Right. A hundred percent. Yeah. It adds a little like, like brevity to those se really serious moments to be able to feel. You know, and I think that at the end of the day, like you being in whatever place whatever your place is in healthcare, in medtech, like whatever role you're playing, like you are helping advance the field, you're helping patient care. And I think always keeping that in mind, even on like the tough days, like you're advancing something in a good way keeps you centered on like your why and drives you forward in a really good way versus like, you know, and I'll be honest, like I, it got hard for me in my CEO role, like, I think I lost my why a little bit and my driver, because it's very hard to see, "Okay, well how am I impacting patient care positively. How am I impacting the world positively?" when you're chasing down insurance reimbursements and whatnot. And, you know, dealing with hospital shutdowns during COVID. So I think at the end of the day, I realize like I need to find a way for this to be enjoyable and fun because I also realize like I'm my best self and I'm more creative and I'm more in like a problem solving zone when I'm in that, that good mindset. And so I, I look at it as a huge positive to, to figure out what, what drives you and make you happy. [00:19:51] Lindsey Dinneen: Yeah. What drives you makes you happy. And I agree with you, if you can also take a step back sometimes and have that broader perspective and mix it with just a little bit of humor, even if just all you're doing is taking a quick break and watching, I don't know, a funny cat video or something. Yeah. [00:20:10] Logan McKnight: Sure. [00:20:11] Lindsey Dinneen: Reset moments make a difference. So difference, you're a board member of several organizations and I wondered if you could speak a little bit to those organizations and what led you to get involved with them. [00:20:24] Logan McKnight: Yeah. So the two I'm on the board of is one Nepal's Spine Foundation which I went to Nepal with a few surgeons I worked with. And then when I was in figuring out my why when I stepped away the surgeons who are started the foundation invited me to join the board. And actually I will be going to Nepal with them in April and we'll be doing another mission and then hiking to Everspace camp together. I'm looking forward to that, and it's been amazing 'cause I think that's also, I've gotten to go on a lot of mission trips in my career. I've gotten to go to Ghana and Barbados, Dominican Republic, Nepal, India. And so, like I also realized like impact being my driver, like I have so much impact to teach people about neuromonitoring, which isn't a well-known, you know, aspect of surgery always. And so the fact that I could leave a hospital, a community better for going there really was a driver. So the fact that I continued to do that work is really important. And then the second is STRIPES, which is how I met you, women in medtech. And you know, the nice thing is I was looking, I was a, I went back before I fully launched GoodKnight Consulting and became like a device rep just to kind of figure out, you know, do I wanna go back into sales? What do I really wanna do? And I was a little lost and I found my way, you know, I wanted community. And when I found this group, it was just transformative for me. Like I, my mentor was Lisa Jacobs, who is phenomenal and has been inspiring for a very long time. And she actually really pushed me to do my dream and start and really put all into my coaching and consulting. So I'm really grateful for that. And then she invited me to be on the board. So like to continue to give back to an organization that I feel like personally gave me, like it, it's why I am where I am today. It gave me that push I needed in that support. And there's tons of women in the organization like Claire Davis, Kat Hurd, like Courtney Turich. I just, they're all out there, they're all public on LinkedIn. And that was something that honestly, initially scared me. And so just, I was inspired by them, supported, and I think that's a really, you know, great thing when you are becoming an entrepreneur is finding your community and that support. [00:22:42] Lindsey Dinneen: Yeah. Yeah. Well, okay. So I just, I love the fact that you're doing both of those things. The mission work is really cool. It's amazing to hear how you've gotten to use-- well, because you're so driven by impact how you've gotten to do that and then make a big difference in, in the lives of people that, yeah, may otherwise never have had that opportunity or, you know, at least not for a while or whatever. So. [00:23:09] Logan McKnight: Right. [00:23:10] Lindsey Dinneen: Yeah, that, that's really incredible. So, you know, through that or throughout your career, are there any moments that really stand out to you as kind of affirming, "Wow, I am in the right industry at the right time." [00:23:23] Logan McKnight: You know, I think medtech, like always, even if it's not me and something I'm doing, like seeing people who I know in the industry and accomplishments they've made, and organizations that I've either been a part of or supported in some way in my career, like just seeing like the new tech coming out and the advancements they're making, just reaffirms like I'm part of a bigger picture in an ecosystem that's really great. And even, you know, like I, I came from the spine space when I was doing medical device and it spine is, you know, tough. Like ortho's tough, spines tough. That's a lot of competition. But you know, I think. Competition drives quality, and so it's really cool even if you see your competitor doing something, you know, you're like, "Oh man, I wish we would've," but it's getting done. It's, you know, it's pushing the envelope, it's making it better. And I think that's huge. And, you know, really exciting too when I found you and Project Medtech to see how you guys are helping support like startups and investors and people who are looking to get into this space. Because I think that's the other thing is getting fresh perspective and new innovative companies helps everybody like drive, drives the mission forward, drives the impact forward on patient care. [00:24:38] Lindsey Dinneen: Yeah. Yeah. I love that. Yeah. And okay, so another very random thing that I found on your LinkedIn, but I just really liked it 'cause I resonate with this aspect. So you started to paint, you learned how to paint. Tell us about that and does that play a role in your creativity overall, do you think? [00:25:01] Logan McKnight: You know, I think so. So I hosted like a happy hour for girlfriends and we did this thing where we painted like a thrift shop thrift store paintings and like Halloween things in them. And so, and I live in the Pacific Northwest, which is beautiful. We have a hundred year old cabin on three acres, and it's, it was October. It was just like, stunning. And I was looking out in our, my backyard and I was like, "I wanna paint this." And I just sat down. I mean, I'm not artistic. I've never and it looked like a 8-year-old painted it and my partner Joe was like, "Maybe watch a video." It's great. I love it. But, you know, and so I found, you know, like Bob, apparently all, every episode of Bob Ross was on Netflix at least last year. And so I just started watching some videos and some videos on YouTube, and I started getting better and better pretty quickly. Like I, you know, I started, you know, little tutorials here and there. And then I realized, like I was also reading books to help me kind of get in this entrepreneurial mindset like growth mindset or "Mindset" by Carol Dweck, which talks about growth mindset. And I realized like, you can teach yourself to do anything. Like I had told myself for the longest time, I mean, I started my I'm 40 and so I told myself for 40 years, like, "I'm not artistic." That was my box I painted around myself. And then all of a sudden I was like, "Well, let's give it a shot." And so, you know, there's, I realize like you set these boundaries in your parameters in your head and you blow them up a little bit. Like, you know what? Like, let's just see, let's try you know, and I see this with our teenagers too, it's sometimes like when they struggle in school, they'll be like, "I'm not smart, or I'm not this." And I'm like, "You just have to try." Like anything worth doing takes effort. And if everybody quit because they weren't good. The first time or even like the 10th time, like imagine how little progress we would make as a society. So I think if something you wanna do something recognizing, like you can learn to do it. And I think that also helped ignite, like me knowing I could be, do my consulting company and really launch it. And so I just started reaching out to people who had done it and I hired coaches and I started to learn more about what would make it work and what I would need to do. And you know what a novel idea, right? You find the person who's doing what you wanna do and you learn from them. You know, and it's just like that entire journey over the last year was really helpful to, I think, get me to the head place like I needed to be, to like leave the safety of a W2 job and launch a company. Just to like lie, you know, to myself every, and be like, "You can do it." Because, you know, if you start every day with the, "I don't know if this is gonna work," like I, there's no way I would've done this. I really had to tell myself I could do it, it was gonna work, and I realized now that I've gotten past that, it's very harder like to put a boundary around me now. Like now it's a challenge, right? Like if you tell me I can't do something, I'm like, "Oh, let's see." I bet you, you know, even if I'll fail, like the first few times, I want to try to see if I can do it because I now have this delusion that I can teach myself to do just about anything, so. [00:28:18] Lindsey Dinneen: That's awesome. [00:28:20] Logan McKnight: Or not. [00:28:20] Lindsey Dinneen: Yeah, no, that is incredible. And you're absolutely right. I think we can all relate to, at least in some element of our lives, painting boxes around ourselves and going, "I'm not this," or "I'm not that," or "I'll never get to be able to do this. I'll never be proficient." And those things aren't true. It's just what we tell ourselves. So I love the fact that painting opened up those doors for you. [00:28:43] Logan McKnight: Yeah. No it's so true. And I think it's like a. You know, a metaphor for life. And I think I hear that a lot of times from people will be like, "I wish I could do what you," and I'm like, " You can literally do anything." That's how crazy. And, you know, we're in peak New Year's resolution time, right? And I think a lot of people are like, "Oh, I wanna do this and do that." And that's like, you can, you just like, if you wanna be a person that exercises more. Just go start exercising. That's how wild the world, like our brains can make us do whatever we want. So anyway, I'm also a big psychology buff 'cause I, I'm a big believer in like the power of the human brain and what it can do over your decision making and your life and the impact it can have, you know, everything really. [00:29:27] Lindsey Dinneen: Yeah. No, absolutely. Yeah, I couldn't agree more. I love that perspective and yeah, growth mindset is a wonderful gift because, you know, you can explore, you can try, and as long as you're sticking with it and doing those things, then you're not failing. You're just, you're just exploring and then you can just keep exploring and find things that are right for you. And you know, not everything will stick, and that's okay too, so. [00:29:55] Logan McKnight: Yeah, a hundred percent. Yeah. I always tell people "I'm still figuring what I, or figuring out what I wanna do when I grow up." You know, and I think that's an ongoing thing, and I hope when I'm 80, I still am figuring out like what's next. [00:30:06] Lindsey Dinneen: Yeah. [00:30:07] Logan McKnight: It's exciting. So. [00:30:08] Lindsey Dinneen: Yeah. All right, well pivoting the conversation a little bit just for fun. Imagine that you were to be offered a million dollars to teach a masterclass on anything you want. It could be within your industry, but it doesn't have to be. What would you choose to teach? [00:30:24] Logan McKnight: You know, I think this, it ends up being the thing I talk about most. And it's the thing I think I wanted to do initially, but it was really a struggle to just target and talk to managers, especially like frontline managers. But I think that transition from being an independent contributor to becoming a first time leader-- like if I could teach a masterclass in that, I think that would be really fun. I see so many very empathetic and like capable independent contributors, whether they be like rockstar sales rep or even a great like technologist or engineer. And then they were like, "Okay, well I need to move up the ladder. I'm gonna be a people manager," and then their next step is people management. And they're like, "This sucks. Like I, nobody told me about like all the things I have to deal with and the people." And you're still in the mindset of like box checking, of like, in order to be successful, "I have to do all these things. I have to do X, Y, and Z." And I think that the second I stopped checking all the boxes and trying to do all the things was when I went from being like a manager to an actual leader of people and activating them. And if I could just get a few people who I believe, like I've even seen so many really great people leave the industry because they feel like they want to advance, but they don't see because they weren't a good manager, like, "Well, how would I ever be a good director or a good VP," or so on and so forth. The reality is like probably the hardest transition is going from independent contributor to a manager, and yet it's like the least supported space. So that's I think that's something I feel deeply passionate about and would love to like able to offer as a resource more for people. [00:32:10] Lindsey Dinneen: And that would be an incredible masterclass. Okay, and then how do you wish to be remembered after you leave this world? [00:32:18] Logan McKnight: I love that one. I mean, I think at the end of the day, that's the impact thing. You know, and I don't even think it has to be this, like, big, you know, like, "Oh, I, you know, solved healthcare in Ghana." Like, you know, it's not that. It's almost like I, I hope that like my company and my interaction with people leaves everyone feeling a little lighter, a little happier, like a little more capable to do like something, and they feel like talking with me, working with me has unlocked like the next level of something that they've been struggling with and makes them feel like, "Okay, I can do this now." 'Cause I almost feel like that's what, what coaching and consulting comes down to is I'm not doing the thing for anybody. I am only helping to remove the roadblock around them, that they stop limiting themselves and they really see what's possible just by making a few changes in the way they think, in the way they operate their business or run their team. And, you know, amazing things happen. So my hope is that I just continue to get to do that and have people that really feel positive impact from that. [00:33:26] Lindsey Dinneen: Yeah. Well that is a beautiful legacy, so, yeah. All right. And then final question. What is one thing that makes you smile every time you see or think about it? [00:33:38] Logan McKnight: Oh, gosh. Well, we just talked about this before our call, but my dog, I have, I'm an animal lover, and so I have the fortune that every day, most every day I'm in my home office and I get to go on a hike or walk with my dogs, either around our property or out somewhere in beautiful Washington. And I think just like seeing the mountains and being out with my dog, like that just makes me smile. And I think it's also what inspired me to paint and all the things. So I, I think just all the beauty like in the world just makes me smile and makes my heart very happy. [00:34:12] Lindsey Dinneen: I love that. Oh my goodness. That's beautiful. All right, well this has been an amazing conversation, Logan. I so appreciate you and your time today. And we're so honored to be making a donation on your behalf as a thank you for your time today to the American Society for the Prevention of Cruelty to Animals, which is dedicated to preventing animal cruelty in the United States. So thank you for choosing that organization to support and we just wish you continued success as you work to change lives for a better world. [00:34:43] Logan McKnight: Yeah, thanks for having me. We'll talk soon. [00:34:45] Lindsey Dinneen: Sounds good. Thank you and take care. [00:34:49] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.
Check out host Bidemi Ologunde's new show: The Work Ethic Podcast, available on Spotify and Apple Podcasts.Email: bidemiologunde@gmail.comIn this episode, host Bidemi Ologunde sits down with JoJo Kalita, Vice President of Partnerships and ACTOverse at ACTO. JoJo is a tech leader with over a decade of experience across Operations, Customer Success, and now Partnerships, where she's helping shape the AI landscape through collaborations with global industry leaders, including work in life sciences and beyond. How do you build operational systems that drive efficiency without losing the human touch? What does "customer obsession" look like when your job is no longer customer-facing, but partnership-driven? And how can emotional intelligence turn mentorship into a ripple effect of real impact? JoJo shares the lessons behind her relationship-first leadership style, her approach to choosing the right partners, and how to leverage technology in ways that stay grounded in empathy, clarity, and outcomes.Sponsors and partners:Promeed: 100% mulberry silk pillowcases and bedding that feel incredibly soft, stay breathable, and are naturally gentle on hair and skin.SurviveX: professional-grade FSA/HSA eligible first aid and preparedness kits designed in Virginia, USA and produced in an FDA-registered facility.Alison US CA: Alison is the world's largest free online learning and skills-training platform, helping more than 50 million learners in 193+ countries build career-ready skills with 6,000+ free courses, certificates, and diplomas.eSign (iOS only): eSign is a clean, privacy-first document-signing app that works entirely on your device, letting you sign PDFs, DOCX files, images, and scans, edit and assemble pages, and export crisp 300 DPI PDFs in seconds, without accounts, cloud uploads, or compromising sensitive documents.Support the show
This is a Vintage episode from 2007.Why This Episode MattersBaking isn't magic; it's chemistry. Gail explains ingredient function so you can so you can bake with intention rather than habitLearn how to substitute intelligently (yogurt for buttermilk, butter vs lard, etc.) without sabotaging structure The episode is packed with practical fundamentals: tools, pantry essentials, pie crust fat choices, and why ice cream flavors must be stronger before freezing.The BanterMark Pascal and Francis Schott open with a recap of a “Duckathlon” with other restaurants— assessing steak, cheese, birds, and brandy. They then pivot hard into food-label transparency and why consumers should be allowed to know what's been done to their food.The ConversationGail Sokol joins to explain why baking differs from cooking and what you need to know. She breaks down how acid-base reactions relate to texture and how her book teaches technique. They also get into real-world home baking: what tools matter, what belongs in your pantry, why lard makes flaky crust, and how to make ice cream that doesn't taste flat once frozen. (Caution: May require sampling.)Timestamps0:00 – “Duckathlon” recap: IDing steak, cheese & mystery birds4:40 – FDA labeling debate: transparency vs “choice” rhetoric9:30 – Gail Sokol joins: baking is science, leavening explained17:10 – Why her book teaches methods: visuals, steps, and understanding ingredient roles20:40 – Home baker essentials: mixer, bowls, spatulas, & whisks 24:00 – Pie crust: butter vs lard; why blends work29:40 – Ice cream fundamentals: pre-chilling, flavor “punch,” serving temperatureGuest BioGail Sokol is an award-winning professional baker and college-level baking instructor. She's the author of About Professional Baking: The Essentials, a fundamentals-first baking guide focused on methods, ingredient function, and technique.Show InfoAbout Professional BakingBy Gail SokolGail's site https://chefgailsokol.com/Join us on March 12 for a wine dinner with BallettoClick below for more info:https://www.stageleft.com/event/31226-balleto-winemaker-dinner-w-anthony-beckman/ Become a Restaurant Guys' Regular!https://www.buzzsprout.com/2401692/subscribeMagyar Bankhttps://www.magbank.com/Withum Accounting https://www.withum.com/restaurantOur Places Stage Left Steakhttps://www.stageleft.com/ Catherine Lombardi Restauranthttps://www.catherinelombardi.com/ Stage Left Wineshophttps://www.stageleftwineshop.com/ To hear more about food, wine and the finer things in life:https://www.instagram.com/restaurantguyspodcast/https://www.facebook.com/restaurantguysReach Out to The Guys!TheGuys@restaurantguyspodcast.com**Become a Restaurant Guys Regular and get two bonus episodes per month, bonus content and Regulars Only events.**Click Below!https://www.buzzsprout.com/2401692/subscribe
Cattitude - Cat podcast about cats as pets on Pet Life Radio (PetLifeRadio.com)
On this episode of Cattitude, Michelle Fern welcomes veterinarian Dr. Heather Davis, Director of Clinical Affairs and Veterinary Services for Pegasus, to discuss hypertrophic cardiomyopathy (HCM)—a surprisingly common heart disease that affects about 1 in 7 cats. Often called a silent killer because symptoms can go unnoticed until the disease is advanced, HCM is something every cat parent should know about. Dr. Davis explains what causes HCM, why certain breeds like Maine Coons, Ragdolls, and Sphynx cats may be at higher risk, and how veterinarians diagnose and manage the condition. She also shares a simple “breath test” cat owners can do at home to help detect early warning signs while their cat is sleeping. Plus, Michelle and Dr. Davis discuss new advances in veterinary medicine, FDA-approved treatments for feline heart disease, and the importance of working closely with your veterinarian instead of relying on “Dr. Google.” If you love your cat and want to stay proactive about their health, this informative episode is a must-listen.EPISODE NOTES: The 30-Breath Test That Could Save Your Cat's LifeBecome a supporter of this podcast: https://www.spreaker.com/podcast/cattitude-the-1-cat-podcast--6666768/support.
The founders of Hershey, Good Humor, Stouffer, Heinz, Kellogg, Kraft, and Birdseye, among others, were pioneers looking to bring clean, hygienic, healthy, and trustworthy products to a market saturated with the opposite. Each specialized in a product, be in chocolate, ice cream, prepared meals, ketchup, cereal, cheese, or frozen foods. Recently we have learned that the grandson of the inventor of Reeses's Peanut Butter cups, owned by Hershey today, has accused the company of destroying the original product, changing "milk chocolate" and "peanut butter" to substances that mirror them. Whereas Milton Hershey sourced fresh milk and used minimal ingredients, modern Hershey products are anything but fresh or even what the label implies. Also, at least 111 substances of unknown safety have been added to foods, drinks and supplements sold in the United States without alerting the US Food and Drug Administration, a new investigation found. This is on top of the exposure that has recently been brought to American foods in general, from food coloring to preservatives - leading companies to change their ingredient lists with a promise of never again lying to consumers. What were companies that attempted to bring purity to a contaminated marketplace, largely resulting from overcrowded cities, has turned ironically into the very thing that they were formed to fight. Now under "trusted brands" the foods that poisons Americans a century ago have made a reemergence.*The is the FREE archive, which includes advertisements. If you want an ad-free experience, you can subscribe below underneath the show description.
We've had many conversations on Raise the Line about the challenges of health communication in today's world of information overload, but none of our guests have the kind of expertise Dr. Tesfa Alexander has acquired in a career that has taken him from Madison Avenue to the halls of government and academia. From guiding tobacco education research at the FDA to leading public health initiatives at MITRE, Dr. Alexander has developed a deep understanding of the science and strategy behind effective health communication. “Successful campaigns keep the long game in mind where you want to develop a lasting relationship with your target audience,” he tells host Lindsey Smith. That relationship needs to be built on understanding culture, beliefs, priorities and daily realities, and only then can you develop messaging that will resonate, he explains. Dr. Alexander also believes these relationships can be leveraged to help people sort out facts from misleading or inaccurate claims. “I strongly recommend shifting our focus from combating misinformation head on, and instead working with the communities who we are seeking to serve.” This fascinating look at communication science also covers: How stories drive belief; The importance of working with community partners who are trusted messengers; The power of audience segmentation. Tune in as Dr. Alexander unpacks what it takes to influence beliefs, and ultimately behaviors, in an era defined by misinformation and institutional mistrust. Mentioned in this episode:Lerner Center for Public Health Advocacy If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
In this episode of On Rare: Innovators, hosts David Rintell, Head of Patient Advocacy at BridgeBio, and Mandy Rohrig, Senior Director of Patient Advocacy at BridgeBio, speak with Kat Bryant Knudson, Founder and CEO of the Speak Foundation and a leader in the limb-girdle muscular dystrophy (LGMD) community. Diagnosed as a child after experiencing early symptoms of muscle breakdown, Kat spent years searching for answers before receiving a definitive genetic diagnosis. What began as a personal journey to understand her condition evolved into a lifelong commitment to ensuring that no one with LGMD faces that journey alone. From founding the Speak Foundation in an unexpected twist of fate to organizing groundbreaking scientific workshops that bring patients, researchers, industry, and the FDA to the same table, Kat has helped reshape how the LGMD community connects, advocates, and advances research. Guided by the belief that people with lived experience should have the loudest voice in the room, Kat continues to innovate on behalf of a diverse and growing rare disease community. Kat's story is a reminder that progress begins with connection, shared experience, and the courage to speak up. Pantene is a third-party trademark. BridgeBio is not affiliated with or endorsed by Pantene or Procter & Gamble, and this reference is for storytelling purposes only.
For decades, midlife has been framed as a time of decline for women — medically, culturally, and personally. Halle Berry is on a mission to change that. On this episode of The Dr. Hyman Show, she shares how her own menopause journey exposed how little real support exists for the 60 million women navigating this transition. That experience ultimately led her to create ReSpin, the community she couldn't find when she needed it. Watch the full conversation on YouTube or listen wherever you get your podcasts. We discuss: • Why menopause is often missed — and how to take back control of your energy, mood, and metabolism • What changes in your brain, bones, and muscle and how to protect them in midlife • How comprehensive testing gives you a personalized roadmap for this phase of life • Why fatigue, low libido, and brain fog aren't “just aging” — and what improves when you address the root cause Your second act can be your strongest. It's a chance to reclaim your strength, your energy, and your future on your own terms. This conversation was recorded live at the Eudēmonia Summit. View Show Notes From This Episode Get Free Weekly Health Tips from Dr. Hyman https://drhyman.com/pages/picks?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Sign Up for Dr. Hyman's Weekly Longevity Journal https://drhyman.com/pages/longevity?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Join the 10-Day Detox to Reset Your Health https://drhyman.com/pages/10-day-detoxJoin the Hyman Hive for Expert Support and Real Results https://drhyman.com/pages/hyman-hive This episode is brought to you by Seed, BIOptimizers, PerfectAmino, BON CHARGE, Made In Cookware and Maui Nui. Go to seed.com/hyman and use code 20HYMAN to get 20% off your first month. Head to bioptimizers.com/hyman and use promo code HYMAN at checkout to save 15%. Go to bodyhealth.com and use code HYMAN20 to get 20% off your first order. Upgrade your routine. Head to boncharge.com/hyman and use code HYMAN for 15% off. Head to madeincookware.com and use the code DRHYMAN for 10% off your order. Learn more about the health benefits of venison and how to get yours, head over to mauinuivenison.com/hyman. (0:00) Halle Berry's health journey and the overlooked issue of menopause (1:21) Introduction to the Eudaimonia Summit (3:27) Women's health problems: Causes and personal stories (7:12) Misdiagnosis, confusion, and the mission to educate (10:01) Women's Health Initiative study and FDA updates (12:48) Hormone therapy and perimenopause symptoms (17:22) Lifestyle's role in hormonal health and disease prevention (22:12) Alcohol, nicotine, and long-term health risks like Alzheimer's (25:26) Early hormone replacement therapy and personalized care (28:15) Sexual health discussions and Halle Berry's ReSpin initiative (32:22) Cultural change, low-tox living, and structural health in menopause (37:01) Menopause symptoms variability and addressing health disparities (39:52) The need for medical education reform and JoyLux's contribution (41:12) Psychedelics in mental health treatment (43:43) Closing remarks and listener engagement (44:00) Disclaimer about podcast content
On today's episode, Andy travels to Austin to visit with Ways2Well founder Brigham Buhler at his Longevity Lab lab to discuss the search for the genetics secrets to eliminating chronic disease and how some species seem to live forever. They dig into why how the field is practiced today often leave patients without real answers, and why Buhler believes a more preventative, patient-focused approach could change that. Change Agents is an IRONCLAD Original Chapters: (00:00) Intro (02:08) Redesigning the Clinic: Making Healthcare Fun (07:10) How Insurance & PBMs Broke the Medical System (14:42) Big Pharma's War on Compounding & Telemedicine (18:22) Why Your Doctor Is Trapped in a Broken System (21:18) Ways2Well Tour: 80s Nostalgia & UV Murals (30:52) The Opioid Crisis & Brigham's Origin Story (38:25) Fighting the FDA & The Illusion of Surgical Safety (43:47) What Are Peptides & Why Pharma Wants Them (48:22) ALLEN: The Ways2Well AI Health Assistant (52:14) Debunking Medical Myths: Testosterone & HRT (58:16) Wearables & The Future of Proactive Health (01:10:57) Inside the Lab: Stem Cells, Red Light, & Hyperbaric Oxygen (01:17:48) Next-Level Detox: Blood Filtration (IBU) & Ozone Saunas (01:20:25) Gene Editing & The Future of Human Evolution Sponsors: Firecracker Farm Use code IRONCLAD to get 15% off your first order at https://firecracker.farm/ GHOSTBED: Go to https://www.GhostBed.com/IRONCLAD and use code IRONCLAD for an extra 15% off sitewide. Subscribe on Apple Podcasts: https://podcasts.apple.com/us/podcast/change-agents-with-andy-stumpf/id1677415740 Subscribe on Spotify: https://open.spotify.com/show/3SKmtN55V2AGbzHDo34DHI?si=5aefbba9abc844ed Learn more about your ad choices. Visit megaphone.fm/adchoices
On this episode of Vitality Radio, Jared sits down with Roz Marchant, founder of Hair's A Million, to explore the surprising story behind a natural hair health breakthrough. After losing her hair during cancer treatment, Roz began researching nutrient-dense, toxin-free ingredients that could support healthy hair and scalp function. What started as a personal experiment eventually became a widely used hair serum developed with a focus on clean ingredients and topical nutrition. Jared also shares the science behind his Hair Revive formula, created to address common internal factors linked to hair thinning such as nutrient depletion, stress, and hormonal shifts. Together they discuss the inside-out approach to supporting hair health, how lifestyle and nutrient status may influence hair growth cycles, and why ingredient integrity matters in both supplements and personal care products. If you're interested in natural strategies that support stronger, fuller, healthier hair, this episode is packed with insights.Products:Hairs a Million ProductsRidgecrest Herbals Hair ReviveBuy Hairs a Million Nutrient Infused Hair Serum AND Ridgecrest Herbals Hair Revive and get $20 off (for 30 days from air date)Thyme Out (Vitality Radio POW! Product of the Week 25% off with PROMO CODE: POW30)Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
About the Guest(s): Dr. Chad Woolner is a chiropractic physician who brings a wealth of knowledge and experience in utilizing advanced technologies to enhance patient care and wellness, including the use of laser and light-based therapies. Dr. Woolner has established himself as a credible voice in chiropractic care and is widely recognized for his expertise in integrating innovative treatments. Dr. Andrew Wells is an accomplished expert in natural health solutions, with a strong focus on the synergy between technology and healthcare. He collaborates closely with Dr. Woolner in providing insights into effective health practices, including weight loss strategies through cutting-edge light-based therapies. Episode Summary: In this engaging episode of the Laser Light Show, Dr. Chad Woolner and Dr. Andrew Wells discuss ground-breaking developments in light-based therapies, specifically focusing on weight and fat loss. The conversation revolves around Erchonia's latest technological advancements that promise to transform traditional approaches towards managing obesity and promoting healthier lifestyles. They introduce the new Zerona Z8 laser—an FDA-cleared, high-intensity violet laser designed to increase cellular energy and stimulate weight loss, offering new hope and tools for both individuals and practitioners. The episode delves into the rising challenges and perceptions surrounding obesity, weight loss interventions, and the growing popularity of GLP-1 medications. It highlights the importance of integrating tools like Zerona lasers with holistic lifestyle changes for a sustainable weight loss solution. Dr. Woolner and Dr. Wells stress the critical role of cellular energy in weight management and how addressing mitochondrial dysfunction can mitigate the obesity epidemic facing many. They advocate for an energy-first approach that prioritizes physiological health to facilitate consistent long-term behavioral shifts in diet and exercise regimens, ultimately fostering a more balanced and sustainable lifestyle. Key Takeaways: Light-based therapies, like the new Zerona Z8 laser, can revolutionize weight loss treatments by enhancing cellular energy and supporting long-term lifestyle changes. Chronic health issues and weight management difficulties often stem from insufficient cellular energy, making it essential to address mitochondrial dysfunction. The popular notion of light therapies as quick-fixes for melting fat fails to capture the full potential of these technologies as catalysts for broader health improvements. Incorporating tools like lasers with lifestyle adjustments, such as breath work and optimizing circadian rhythms, provides a comprehensive approach to weight loss. A successful weight loss strategy intertwines modern technological interventions with patient dedication to lifestyle changes, offering both immediate and enduring health benefits. Notable Quotes: "The paradigm shift with light-based therapies isn't just about melting away fat, but how they can act as a catalyst for sustainable energy and behavior change." - Dr. Chad Woolner "Patients often lack the physiological energy needed to make lasting lifestyle changes, and that's where therapies like the Zerona laser play a crucial role." - Dr. Andrew Wells "It's about solving mitochondrial dysfunction to empower and enable individuals to make healthier choices consistently." - Dr. Chad Woolner "When you increase your body's capacity to produce more energy, it not only supports weight loss but overall wellness and quality of life." - Dr. Andrew Wells "Using the Zerona laser as a catalyst can completely change someone's energy and mindset, paving the way for long-term health benefits." - Dr. Chad Woolner Resources: Erchonia's Zerona Lasers Book: Brain Energy by Dr. Chris Palmer Dr. Andrew Huberman podcast on circadian rhythm Enhance your understanding of cutting-edge weight loss technologies by listening in on this enlightening episode. Stay tuned for more insights from Dr. Chad Woolner and Dr. Andrew Wells on the Laser Light Show, revealing how innovative therapies and holistic approaches can transform health practices.
Most conversations about “AI in Medicine” bore me. I think this is because either we lack the imagination to consider how AI will change medicine in the next decade, or we are not being specific enough about how small parts of medicine could be productively affected.Dr. Shantanu Nundy, MD, MBA, is a practicing physician whom I like to think of as a serial innovator. He is currently an advisor on artificial intelligence to the FDA in the Commissioner's Office. He has spent a great deal of time and energy thinking deeply about what AI can bring us today and in the future. I hope you enjoy this conversation. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe
March 4, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Quest Diagnostics unveils AI chatbot in MyQuest portal analyzing five years of lab data powered by Google's Gemini models Subco launches independent supplement certification program anonymously purchasing retail supplements and verifying ingredients in independent labs Eight Sleep raises funding at $1.5B valuation, shifting from reactive sleep optimization to predictive AI agent and pursuing FDA clearance for sleep apnea detection More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co
Elevance Health's Medicare Advantage plans face federal sanctions. The University of Mississippi Medical Center clinics reopen after a ransomware attack. And the FDA warns telehealth companies about marketing compounded weight loss drugs. That's coming up on today's episode of The Gist Healthcare Podcast. Hosted on Acast. See acast.com/privacy for more information.
In this edition of Essential, we look at two major issues facing pharmacy compounding. First is a state-by-state effort by pharma companies to pass laws restricting compounding, and second is a cryptic statement from the FDA about possible limitations on compounding with GLP-1 ingredients. They're both Very Big Deals for pharmacists across the country. Links FDA statement on GLP-1 drugs: https://www.fda.gov/news-events/press-announcements/fda-intends-take-action-against-non-fda-approved-glp-1-drugs … and APC's response: https://a4pc.org/news/apc-responds-to-fdas-glp-1-statement Stay up to date on our state Compounding Defense Initiative: compounding.com Join APC today: https://a4pc.org/membership Find us on social: LinkedIn: https://www.linkedin.com/company/a4pcrx/ Facebook: https://www.facebook.com/a4pcrx/ Instagram: https://www.instagram.com/a4pcrx/
In this week's episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl unpack a wide range of developments shaping healthcare in America today, including the TrumpRx drug discount program. From new legislation affecting telehealth and pharmacy benefit managers (PBMs) to the rapid spread of measles and growing public concern about vaccine policy, this month's discussion highlights the policy decisions and scientific debates influencing medicine right now. The episode opens with the latest federal legislation passed to avert a government shutdown. While healthcare was not the central focus of this particular political battle, the bill contains several provisions that affect medical practice. These include extensions for telehealth coverage and hospital-at-home programs, reforms targeting PBM transparency and new requirements designed to address “ghost networks” in Medicare Advantage provider directories. Dr. Pearl explains that while these provisions represent incremental progress, they are unlikely to solve the larger problems driving healthcare costs and access challenges in the United States. Here are the other major storylines from episode 104: Healthcare costs remain nation's top concern: A new KFF poll finds that healthcare expenses rank above food, housing and utilities as the economic issue Americans worry about most. Prior authorization frustrations grow: Many patients report delays or denials of care due to insurance requirements, highlighting persistent tension between insurers, physicians and patients. Drug pricing debates continue: Pearl examines a new prescription drug website initiative and explains why it may have limited impact compared with broader policy proposals such as “most favored nation” pricing. Telehealth's uncertain future: Although the latest legislation extends certain pandemic-era flexibilities, the lack of a permanent solution leaves virtual care programs in limbo. PBM reforms move forward slowly: New policies aim to increase transparency and reduce incentives tied to drug list prices, though Pearl notes that meaningful change will depend on future implementation. Site-neutral payment gains attention: A provision requiring unique identifiers for outpatient services could pave the way for policies that eliminate higher reimbursement for hospital-owned facilities providing identical care. Measles outbreaks surge: Nearly a thousand cases have already been reported in 2026, with the overwhelming majority occurring among unvaccinated children. Trust in the CDC declines: Polling shows confidence in the agency has dropped significantly following changes to vaccine recommendations. Independent vaccine review groups emerge: Medical organizations and states are forming new committees to evaluate vaccine evidence as federal guidance becomes more contested. Early colon cancer deaths rise: The death of actor James Van Der Beek at age 48 highlights the growing incidence of colorectal cancer among younger adults and the importance of earlier screening. FDA confusion over a new flu vaccine: The agency initially declined to review Moderna's mRNA-based flu vaccine before reversing course and agreeing to evaluate it ahead of the next flu season. Younger Americans face worsening health trends: New claims data suggest chronic disease is appearing earlier among millennials and Gen Z, driven by lifestyle factors and reduced connection to primary care. Wearable data reveal health disparities: Apple Watch data show significant differences in resting heart rates across states, reflecting variations in lifestyle, access to care and public health conditions. As the episode concludes, Dr. Pearl warns that growing political conflict around vaccines and biomedical research risks undermining public trust in science. The consequences, he argues, could shape American medicine for decades to come. Tune in for more fact-based analysis and discussion of the biggest stories in healthcare. * * * Dr. Robert Pearl is the author of the new book “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn The post MTT #104: TrumpRx, rising measles cases & the politics of vaccine science appeared first on Fixing Healthcare.
Squid Game the Challenge News: These reality stars will be the VIP's in the next season! Savannah Chrisley in trouble with the FDA over her GLP-1s; Where has Anya Taylor Joy been? One Star Reviews; The Five Second rule game!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
If you've ever been dismissed, minimized, or given outdated advice about menopause — this video is for you. Every week in my clinic, I hear the same myths repeated to intelligent, capable women who simply want to feel like themselves again. Unfortunately, misinformation around menopause and hormone therapy is still everywhere — even inside medical offices. Today, I'm addressing 10 of the most common (and harmful) things women are told about menopause — and explaining what the science actually says. We'll discuss: • “Hormone replacement is dangerous. Just take birth control pills.” • “You're only 42 — you're too young for menopause.” • “Your labs are normal, so it can't be menopause.” • “You must wait a full year after your last period to start hormones.” • “You can't start hormones after 60 — or you must stop at 60.” • “Hormones aren't FDA-approved for heart disease or Alzheimer's, so they don't help.” • “You can't take hormones if you have a family history of breast cancer.” • “Testosterone is only for men.” • “Testosterone is just for libido.” • “You can never take estrogen or progesterone after breast cancer.” Menopause care is nuanced. It's individualized. And it should be rooted in evidence — not fear. I'll walk you through what we know today about menopausal hormone therapy, testosterone therapy for women, timing, safety, and why so many women are still being told outdated information. You deserve clarity. You deserve options. And you deserve a provider who understands midlife physiology. Further Reading & Trusted Resources The Menopause Society www.menopause.org Dr. Louise Newson www.drlouisenewson.co.uk Instagram: @menopause_doctor Study referenced in this video: Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study Full paper: http://bit.ly/4tWR9S5 If this video helped you, please share it with a woman who needs better information. Subscribe for evidence-based education on midlife health, hormone optimization, and longevity. Because menopause is not the end of vitality — it's the beginning of informed power.
Laser vs Red Light Therapy: What's Real, What's Marketing, and What Actually Works | Conversations with a Chiropractor Episode Description In this solo episode of Conversations with a Chiropractor, Dr. Stephanie Wautier tackles a question she's hearing everywhere right now: "Are those at-home red light masks basically the same as laser?" A casual moment at the eye doctor turns into a clear breakdown of what's happening in the marketplace, where marketing claims are loud and the science is usually missing. Stephanie explains the core difference in plain language. Most at-home "red light" devices are LED, meaning the light is non-coherent and scatters like a flashlight. A low-level laser is coherent, tightly focused, and built to deliver targeted energy with low beam divergence. That distinction matters because it impacts depth, precision, and what the device can realistically accomplish. From there, she walks through laser classes, safety, and why not all lasers are the same. She also shares why she trusts Erchonia's approach, their research-backed model, and how different wavelengths (red, green, violet) have different biological effects. The big takeaway is simple: not everything that glows red is "laser," and not every claim deserves your money. She also highlights an important caution: even "gentle" photobiomodulation tools can be contraindicated for active cancer, because the same energy that supports cellular activity can be a problem in the wrong context. If you've been flooded with social media promises about the "fountain of youth" in a $75 mask, this episode will help you shop smarter, ask better questions, and understand what you're actually buying.
HOW MUCH DO DENTAL IMPLANTS COST!? Download the FREE Guide to Dental Implants Here: https://bit.ly/46ovKXGWant to know if you may be eligible for Permanent Teeth in 24 Hours? Take the 60-Sec Quiz Here: https://bit.ly/4qQAKfb▬▬▬▬▬▬▬▬ Contents of this video ▬▬▬▬▬▬▬▬▬▬Disclaimer: Nuvia Dental Implant Centers are locally owned and operated by licensed dental practitioners. These locally owned and operated practices are part of a professional network of dental implant centers operated by prosthodontists, oral surgeons, and restorative dentists. Each Nuvia Dental Implant Center has a business affiliation with Nuvia MSO, LLC, a Dental Support Organization that provides non-clinical support to each center.Nuvia Dental Implant Centers are able to provide patients with a bridge made with an FDA approved permanent material, zirconia, in 24-hours. No temporary denture. Not all those who come in for a consultation are medically cleared to receive permanent zirconia teeth in 24-hours. Follow up appointments are required to confirm implant integration and make adjustments if necessary. Results may vary in individual cases. Patients represented in videos are actual NUVIA patient(s) and may have been compensated for their time in telling their story.While soft foods immediately after surgery are generally approved by our clinical team, the local surgeon may give individual instruction on dental implant aftercare according to the specific circumstances applicable to each case.From 2022 through 2024 Nuvia had a documented 99.18% dental implant success rate. During a documented pressure test Nuvia's 24Z teeth withstood 2330 Newtons of Force before breaking.Copyright 2024. Nuvia Dental Implant Centers. All rights reserved.
Have you found yourself wondering why your libido has left the bedroom? Or maybe thinking, why does sex feel different now, and why didn't anyone prepare me for this? If you have felt confused, frustrated, disconnected from your body, or quietly worried that midlife and menopause might mean the end of pleasure, this episode is for you. In this conversation on Pleasure in the Pause, host Gabriella Espinosa welcomes back Dr. Maria Sophocles, board-certified obstetrician-gynecologist, menopause specialist, sexual counselor, and author of the new book The Bedroom Gap: Rewrite the Rules and Roles of Sex in Midlife. Together, they explore what is actually happening to women's bodies in midlife and why so many of us were never properly prepared. Maria Sophocles is a gynecologist, author and public advocate for women's health. Her mission to close the gendered healthcare gap inspired her viral TED talk and book, The Bedroom Gap, about what happens to sex in midlife. Her efforts to provide access to contraception in New Jersey changed the state's constitution. Her virtual clinic serves women in eleven US states and internationally. She is currently working on a documentary about sex and menopause. She is married with four grown children.Highlights from our discussion include:Why the bedroom gap is about more than just the orgasm gap and includes the difference in expectations, abilities, education, medical support, and cultural scripts between men and women around sex and pleasure.The real medical solutions for genitourinary syndrome of menopause symptoms including vaginal estrogen, vaginal prasterone, hyaluronic acid suppositories, and two FDA approved medications for low sexual desire, Addyi and Vyleesi.How shame, inherited sexual scripts, and the androcentric model of sex (sex designed for male pleasure) keep women from speaking up about their sexual health concerns to doctors or partners.Dr. Sophocles's Five M's framework: mind, meds, medicine, movement, and moisture, a roadmap for women who feel overwhelmed and want to reclaim sexual pleasure.Why sexual health is a fifth pillar of longevity, how staying sexually active lowers blood pressure and anxiety, increases lifespan, and combats the epidemic of loneliness.CONNECT WITH Dr. Maria Sophocles:Ep 6TED TalkHot DocumentaryInstagramThe Bedroom Gap BookWebsiteCONNECT WITH GABRIELLA ESPINOSA:InstagramLinkedInWork with Gabriella! Go to https://www.gabriellaespinosa.com/ to book a call.Full episodes on YouTube. The information shared on Pleasure in the Pause is for educational and informational purposes only and is not intended as medical advice. Always consult your healthcare provider before making any decisions about your health or treatment. The views expressed by guests are their own and do not necessarily reflect the views of the host or Pleasure in the Pause.
In this podcast, Orges Alabaku discusses his article, "The Use of VMAT2 Inhibitors for Tardive Dyskinesia," which is published in the March-April 2026 issue of the Journal of Clinical Psychopharmacology. As Dr. Albaku notes, tardive dyskinesia (TD) is a potentially severe and often persistent movement disorder associated with prolonged exposure to dopamine receptor-blocking agents, particularly antipsychotic medications. The only FDA-approved medications for TD are vesicular monoamine transporter 2 inhibitors (VMAT2-Is), valbenazine and deutetrabenazine, while another VMAT2-I medication, tetrabenazine, is used off-label. However, data about VMAT2-I use remain limited. In their study, Dr. Alabaku and colleagues Mark Olfson, T. Scott Stroup, and Tobias Gerhard characterized trends in TD diagnosis and VMAT2-I use among adults with mental health diagnoses receiving antipsychotics by analyzing 2017-2022 MarketScan data. They report that TD remains underdiagnosed, with treatment rates low, highlighting the need for improved TD recognition and VMAT2-I access. doi: 10.1097/JCP.0000000000002155
Check out host Bidemi Ologunde's new show: The Work Ethic Podcast, available on Spotify and Apple Podcasts.Email: bidemiologunde@gmail.comIn this episode, host Bidemi Ologunde connects the dots between three fast-moving signals from Feb 23–Mar 1, 2026: a chokepoint-driven escalation in the US/Israel/Iran war, Europe's shift from "paper sanctions" to physical interdictions at sea, and the growing reality that grids and courtrooms are now battlegrounds. What does it mean when the Strait of Hormuz becomes a frontline? Are maritime seizures the new normal in sanctions enforcement, and what happens when states push back in the gray zone? Can international law and infrastructure strikes reshape alliances faster than diplomats can react? Plus: what should listeners watch next as markets, militaries, and legal institutions collide in real time?On the Bid Picture Podcast, I talk about big ideas, and Lembrih is one of them. Born from Ghanaian roots, Lembrih is building an ethical marketplace for Black and African artisans: makers of heritage-rich products often overlooked online. The vision is simple: shop consciously, empower communities, and share the stories behind the craft. Lembrih is live on Kickstarter now, and your pledge helps build the platform. Visit lembrih.com, or search “Lembrih” on Kickstarter.Sponsors and partners:Promeed: 100% mulberry silk pillowcases and bedding that feel incredibly soft, stay breathable, and are naturally gentle on hair and skin.SurviveX: professional-grade FSA/HSA eligible first aid and preparedness kits designed in Virginia, USA and produced in an FDA-registered facility.Support the show
Want deeper support? Join Circle at holplus.co/circle and use code PODCAST for a one-month trial.Hormone therapy is often framed in extremes. It is either dangerous and cancer-causing, or it is the miracle solution to aging. For decades, women have been told to fear estrogen, avoid progesterone, and accept midlife decline as inevitable. But what if the story around hormones was shaped more by panic and oversimplified data than by the full clinical picture?In this episode of hol+, Dr. Taz sits down with preventive medicine pioneer Dr. Erika Schwartz to revisit the Women's Health Initiative and the ripple effects that followed. Together, they explore how one study reshaped hormone replacement therapy guidelines, why the concept of “class effect” blurred important distinctions between different types of hormones, and how relative risk statistics can be misunderstood in ways that drive fear-based decisions.They also discuss bioidentical hormone therapy, the difference between compounded and FDA-approved options, and how delivery methods like creams, patches, and pellets may affect long-term outcomes. The conversation expands beyond menopause into birth control, progesterone deficiency, teen hormone health, and the broader question of how women can advocate for themselves in a system that often prioritizes protocols over personalization.Rather than promoting blind trust or blanket rejection, this episode focuses on clarity. It invites listeners to understand risk more accurately, ask better questions, and approach hormone care with nuance instead of fear. This conversation is for anyone navigating perimenopause, menopause, hormone therapy decisions, or simply wanting to better understand how women's health became so complicated.About Dr. Erika Schwartz Dr. Erika Schwartz is a board-certified internist and a leading voice in preventive and integrative medicine. After spending 15 years practicing conventional medicine and running a trauma center, she shifted her focus toward prevention, longevity, and personalized hormone therapy.For more than three decades, Dr. Schwartz has advocated for bioidentical hormones and individualized care, teaching physicians, speaking internationally, and helping patients navigate midlife health with a whole-body approach. She founded one of the first compounding hormone pharmacies in New York and has worked extensively in physician education through organizations focused on longevity and preventive medicine.She is the author of multiple bestselling books, including the newly revised edition of Don't Let Your Doctor Kill You, which empowers patients to understand medical risk, advocate for themselves, and make informed decisions without fear.Order the BookDon't Let Your Doctor Kill YouStay Connected:Connect further to Hol+ at https://holplus.co/- Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+.Follow Dr. Erika SchwartzInstagram: https://www.instagram.com/drerikaschwartz YouTube: https://www.youtube.com/@DrErika Website: https://drerika.com/Follow Dr. Taz on Instagram: https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Subscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsGet your copy of The Hormone Shift: Balance Your Body and Thrive Through Midlife and MenopauseHost & Production TeamHost: Dr. Taz; Produced by ClipGrowth.com (Producer: Pat Gostek)
When Lucy Postins started The Honest Kitchen in 2002, she didn't just launch a pet food company — she lobbied the FDA to create an entirely new standard for human-grade pet food. Two decades later, the brand she built is the leading human-grade pet food in North America, with a 50/50 revenue split between e-commerce and brick-and-mortar retail. CEO Will Lisman, who stepped in three years ago after a career spanning Hershey, startup leadership, and brand building, is now scaling the mission while positioning the company against headwinds in affordability, pet adoption, and a category he believes is a decade behind human food in its health-and-wellness evolution.
What if your bloodwork is "normal"—but your health isn't optimized? Lisa Fischer welcomes Regan Archibald back to explore how peptides are redefining longevity, metabolic health, and immune regulation. Instead of waiting for disease, Regan shares how comprehensive lab analysis can identify subtle imbalances in insulin, ferritin, thyroid antibodies, ApoB, and inflammatory markers—then match those findings with targeted peptide therapy. They break down how peptides turn genes on and off, support muscle preservation, enhance neuroplasticity, improve sleep cycles, regulate stress hormones, and reduce systemic inflammation. The conversation also tackles safety, FDA regulation, compounding pharmacies, and why buying research peptides online can be risky. This episode is for anyone curious about epigenetics, advanced lab testing, and personalized health optimization beyond GLP-1 trends. Link to the Little Rock Event: Link to event: https://agelessfuture.com/summit-26-03-20-little-rock/
In this episode, Ellen Csepe introduces transcranial magnetic stimulation (TMS), a novel treatment for depression that has been FDA approved since 2008. She discusses its mechanism, effectiveness, particularly for seniors, and compares it to traditional antidepressants, highlighting its lower side effects. Real patient experiences illustrate the potential of TMS in managing depression, especially for those resistant to medication. The conversation concludes with a call to consider TMS as a viable treatment option for patients struggling with depression. Want to make sure you stay up to date in all things Geriatrics in less than 3 minutes every other week? Join thousands of others in our free MMOA Digest Email list - https://institute-of-clinical-excellence.kit.com/a3837f54b7
Recurrent respiratory papillomatosis (RRP) has long been managed with repeated surgical debulking, sometimes requiring dozens of procedures over a lifetime. In this episode of BackTable, Dr. Aaron Friedman and guest host Dr. Stephen Schoeff discuss a major shift in care: immune-directed therapy targeting HPV 6 and 11. --- SYNPOSIS Dr. Friedman reviews the recent FDA approval of the Precigen product PAPZIMEOS (August 2025), a therapeutic vaccine designed to stimulate HPV-specific T-cell responses. Clinical trial data show that about half of treated adults required no additional surgeries over the following year, with many responders maintaining durable benefit for years. The conversation also covers traditional management strategies, adjuvant therapies like bevacizumab, HPV vaccination, and the evolving algorithm for adult RRP care. --- TIMESTAMPS 00:00 - Introduction02:13 - RRP Patient Types and Symptoms05:06 - Adult vs Juvenile Transmission10:46 - When to Escalate Treatment15:40 - Immunotherapy 18:55 - Trial Enrollment, Results and Dosing Rules26:17 - Durable Long Term Response30:47 - Who Should Get Treated32:34 - Logistics And Public Perception37:50 - Future Research And Prevention --- Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRPhttps://pubmed.ncbi.nlm.nih.gov/41543033/ Dr. Stephen Schoeffhttps://healthy.kaiserpermanente.org/washington/clinicians/stephen-schoeff-6848607 Dr. Aaron Friedman https://www.uchealth.com/en/provider-profiles/friedman-aaron-d-1609057587
The Steve Gruber Show | Freedom's Counterpunch: Iran, SCOTUS & the Billionaire Grab --- 00:00 - Monologue 19:09 – Ali Safavi, member of Iran's Parliament in Exile, the National Council of Resistance of Iran, and President of Near East Policy Research. Safavi provides updates on developments inside Iran and growing unrest. He discusses the regime's stability and what opposition leaders are seeing on the ground. 28:07 – Knox Williams, President of the American Suppressor Association (ASA) Foundation. Williams discusses the ASA Foundation's lawsuit challenging the constitutionality of the National Firearms Act (NFA) registration requirements. He explains the legal arguments and what the case could mean for Second Amendment rights. 38:22 - Monologue 47:13 – Katie Daniel, Director of Legal Affairs for Susan B. Anthony Pro-Life America. Daniel addresses concerns from lawmakers about the FDA's delay in reviewing updated safety data on the abortion pill. She explains the legal and regulatory questions surrounding the issue. 56:47 – Holly Adams, Ohio congressional candidate, lifelong Ohioan, mother of two, and advocate for conservative policies. Adams explains why swing districts like Ohio's 1st are critical to advancing the Trump agenda. She discusses border security, the economy, and grassroots voter engagement. 1:05:35 – Mark Vargas, GOP media surrogate, Editor-in-Chief of Illinois Review, and former Iraq Task Force member in the Office of the Secretary of War (2007–2010). Vargas reacts to reports of celebrations in parts of Iran amid political upheaval. He discusses what shifting sentiment could mean for U.S. foreign policy. 1:15:28 - Monologue 1:24:16 – Dr. Josh McConkey (Ret.), USAF Colonel, emergency physician, military commander, and award-winning author. McConkey analyzes the latest developments in Iran and emphasizes the high stakes for the Iranian people. He shares a powerful comparison from an Iranian-American who likened the moment to France at the start of D-Day. 1:34:00 – Ivey Gruber, President of the Michigan Talk Network. Gruber discusses new policies restricting California schools from withholding information from parents about their children's gender-related decisions. The conversation also touches on “Operation Epic Fury” and reactions inside Iran, including claims that many citizens are hopeful for expanded freedoms. --- Check out our brand new podcast, 'Forgotten America'... The second episode is live NOW at Steve Gruber on YouTube! Link below: https://youtu.be/vZiEUjtQ-m4
Can a strong U.S. biopharma industry be reconciled with the successful emergence of China? And can China be a catalyst of positive change across the global industry, even if this implies some level of rebalancing away from the U.S.? On the latest BioCentury This Week podcast, BioCentury's analysts discuss a Guest Commentary by McKinsey Senior Partner Emeritus Franck Le Deu, who argues that a multipolar biopharma world in which the U.S. continues to thrive even as China becomes meaningfully stronger can emerge.The analysts also discuss BioCentury's latest Rare Disease Spotlight, which focuses on a wave of therapies aiming to activate retinal function in Stargardt disease patients.Turning to FDA, BioCentury Washington Editor Steve Usdin discusses recent public statements by FDA Commissioner Marty Makary, questions about Vinay Prasad's future, and the plausible mechanism pathway.View full story: https://www.biocentury.com/article/658606 #GlobalBiopharma #ChinaBiotech #RareDisease #StargardtDisease #FDAPolicy 00:00 - Introduction02:47 - Multipolar Biopharma World13:39 - Rare Disease Spotlight25:15 - Makary Remarks31:14 - Plausible Mechanism FrameworkTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text
Andi L. Fristedt, former senior official at CDC, FDA and the Senate HELP Committee, heads up a newly established Washington, D.C. office of the Parkinson's Foundation. The Foundation acts in close allegiance with Michael J. Fox and his foundation; advocates; scientific and policy leaders such as Professors Okun and Dorsey; and new voices such as Harvard Professor Sue Goldie. It supports research on the genetic underpinnings of Parkinson's Disease: 13% of Americans have genetic variants that place them at considerable risk. The foundation focuses on therapies and improving the quality of care; education of the public; and strengthening prevention against environmental toxins. The Washington office's mandate is to “connect the dots” between science with those in Congress and the administration able to be champions and shape policy. There is progress: “We just know a lot more. And how to tell our story.” A paramount concern is the pesticide paraquat, which continues to be used widely in the United States, while outlawed in dozens of countries. Over 40 years of scientific research has made very clear the danger paraquat poses, especially to children. The EPA is currently revisiting paraquat, while many states spring into action.
The Middle East faces a major geopolitical shift following a joint U.S. and Israeli operation in Iran that resulted in the death of Supreme Leader Ayatollah Ali Khamenei and several top commanders. President Trump ordered the strike with the goal of "giving the country back to the Iranian people," sparking debate in Washington over executive authority and the War Powers Act. Texas Republican Congressman Pat Fallon, a member of the Armed Services and Intelligence Committees, joins the Rundown to discuss the strategic implications of the attack, and the risk of retaliation at home. With 30 million Americans living with a rare disease, is the traditional "blockbuster" drug model failing the approximately one in 11 people who need specialized care? Judy Stecker, founder of Wheeler's Warriors and former HHS official, joins us to discuss a historic shift at the FDA. From the groundbreaking use of genome editing to treat metabolic diseases to the emotional journey of her son Wheeler, Stecker explains how she believes the science of "genetic patches" has finally outpaced our regulatory system. Plus, commentary by Senior Fellow at the Lexington Institute, Dr. Rebecca Grant. Learn more about your ad choices. Visit podcastchoices.com/adchoices
It's Endometriosis Awareness Month. Ali's guest this week, Holly Abel, was eleven years old when her debilitating periods started. For decades, doctors told her it was “normal.” That she was dramatic. Hormonal. Sensitive. It wasn't normal. In early 2023, Holly was finally diagnosed with severe stage 4 endometriosis — affecting multiple organs throughout her body. Shortly after, she experienced a miscarriage. In December 2023, she underwent major surgery. Then in March 2024, after a routine HSG, everything began to unravel. By early May, she was in septic shock and given a 10% chance to live. In July, a total hysterectomy saved her life… and ended her ability to carry children. Holly talks about all of this and more in an educational, emotional episode about medical trauma, advocacy and survival. EPISODE SPONSORS: THE WORK OF ART BOOK SERIESAli's Children's Book Series about IVF, IUI and Family Building Through Assisted Reproductive Technology https://www.infertileafgroup.com/booksThe 3-book bundle is now just $49 (normally $79)!The latest book in the Work of ART series, “You Are a Work of ART," is for every kiddo born through ART -- and the people who love them.PHERDALIG: @pherdal_sciencePherDal is the world's first and only FDA-cleared, sterile, at-home insemination kit designed to help people build their families in the comfort of home. Created by parents who've been there, PherDal is safe, simple, and affordable—putting more options in your hands as you grow your family. Explore at PherDal.com.Go to PherDal.com today and use code INFERTILEAF for $10 off.BELIIG: @belibabywww.belibaby.com Are you thinking about growing your family? Whether you're just starting to plan or are actively trying to conceive, preconception health is key. Beli has vitamins to help both women and men optimize their health before pregnancy. With essential nutrients like Folate, Iodine, and Zinc, Beli ensures your body is ready for this exciting next step. Give yourself and your future baby the best foundation for a healthy start.Visit Belibaby.com today and use code IAF15 for 15% off your first order. Our Sponsors:* Sign up and get 10% off at BetterHelp dot com. Your emotional wellbeing matters. Find support and feel lighter in therapy. Support this podcast at — https://redcircle.com/infertile-af-infertility-and-modern-family-building-through-art/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
In this episode, Caroline hosts renowned plastic surgeon and star of Botched, Dr. Terry Dubrow, for a “hard questions” episode and some laughs. He educates us on Ozempic/GLP-1 drugs, microdosing, and newer peptide options like tirzepatide and the not-yet–FDA-approved “retatrutide,” which he says may help lower inflammation and support “preservation longevity” while AI accelerates disease breakthroughs. They discuss fears around AI, his belief that people should learn to use it, and his warning about unregulated online/black-market compounds. In beauty, Dubrow urges women to dial back fillers, avoid “Ozempic face panic,” be cautious with deep plane facelifts, and invest more in consistent energy devices (lasers/ultrasound/radiofrequency) rather than extreme procedures. He shares lessons from Botched and Plastic Surgery Rewind, including turning down risky patients, a memorable case removing “concrete” facial injections by reducing—not fully removing—masses, and how he and his wife test wellness trends on their “Doctor and Mrs. Guinea Pig” channel. He also covers peptides uncertainty, cycling use if someone insists, creatine findings, daily visualization, and marriage rules for handling conflict.Find Dr Dubrow - Website: www.drdubrow.com- Instagram: @drdubrow- TikTok: @drterrydubrow- Botched Presents: Plastic Surgery Rewind on E! and PeacockFollow Caroline:- Podcast: https://being-caroline.com/podcast/- IG: https://www.instagram.com/shop.with.caroline/- TikTok: https://www.tiktok.com/@shop.with.caroline- Facebook: https://www.facebook.com/beingcaroline- Search Looks: https://www.shop-with-caroline.com/- Shop New Merch: https://shop.dearmedia.com/collections/coming-in-hotPlease note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Sponsors:Text HOT to 64000 to get twenty percent off all IQBAR products, plus FREE shipping. Message and data rates may apply.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Contributor: Taylor Lynch MD Educational Pearls: Melatonin is an endogenous hormone released primarily by the pineal gland Also released by extrapineal regions in the retina, the GI tract, and some immune cells Peak secretion occurs at night and is suppressed during the day Secretion and production decrease with age Older patients experience the greatest improvement in sleep latency and sleep quality Mechanism of action in the suprachiasmatic nucleus of the hypothalamus MT1 receptor Reduces normal firing MT2 receptor Shifts the circadian rhythm FDA approved for insomnia Decreases sleep latency by 7 minutes Increases total sleep time by 8 minutes FDA approved for circadian sleep-wake disorders Jet lag Most effective in west-to-east travel Best if crossing at least 5 time zones Shift work A study examined ED physicians and nurses with rotating shifts Modest increase in deep sleep percentage No difference in cognition or reaction time the day after taking melatonin Nurses on rotating night shifts experienced increased total sleep time by 20 minutes Dosing 0.5 - 3 mg is the most evidence-based dosing Higher doses increase the risk of rebound grogginess but do not improve outcomes References Ahmad SB, Ali A, Bilal M, et al. Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders. Cell Mol Neurobiol. 2023;43(6):2437-2458. doi:10.1007/s10571-023-01324-w Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;(2):CD001520. doi:10.1002/14651858.CD001520 Morgenthaler TI, Lee-Chiong T, Alessi C, Friedman L, Aurora RN, Boehlecke B, Brown T, Chesson AL Jr, Kapur V, Maganti R, Owens J, Pancer J, Swick TJ, Zak R; Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep. 2007 Nov;30(11):1445-59. doi: 10.1093/sleep/30.11.1445. Erratum in: Sleep. 2008 Jul 1;31(7):table of contents. PMID: 18041479; PMCID: PMC2082098. Thottakam BMVJ, Webster NR, Allen L, Columb MO, Galley HF. Melatonin Is a Feasible, Safe, and Acceptable Intervention in Doctors and Nurses Working Nightshifts: The MIDNIGHT Trial. Front Psychiatry. 2020;11:872. Published 2020 Aug 27. doi:10.3389/fpsyt.2020.00872 Summarized and edited by Jorge Chalit, OMS4 Donate: https://emergencymedicalminute.org/donate/ Join our mailing list: http://eepurl.com/c9ouHf
Pharma ads, biotech IPOs, $1M longevity programs, oh my!This month's Digital Health Download skews towards biotech, which is having a moment. Tune in to hear Halle and Michael cover the latest headlines.We cover:Why pharma ads are surging and the growing push for restrictions on D2C drug advertisingHims & Hers' $1.15B acquisition of Eucalyptus, its global expansion strategy, and the FDA crackdown on compounded GLP‑1 drugsThe return of biotech IPOs, with Eikon Therapeutics and Generate Biomedicines signaling investor interest in platform‑based drug discoveryVaccine makers scaling back research amid policy uncertainty, declining uptake, and tighter fundingTrumpRx's “most favored nation” drug pricing approach, and what one STAT analysis foundBryan Johnson's $1M per year “Immortals” longevity program—Show notes:Should drug companies be advertising to consumers? (The New York Times) Hims & Hers Enters $1.15 Billion Agreement to Acquire Eucalyptus (PharmExec.com)A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all (STAT)Vaccine Makers Curtail Research and Cut Jobs (The New York Times) TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics (STAT)Bryan Johnson's Immortals: $1M to try longevity regimen (Axios) —"Halle Tecco wanted to see tech used for better medical services and getting people engaged in their own health. Now, she's written a book on how she went about it." - The WSJMassively Better Healthcare is out now!—Rock Health's annual CEO Summit is returning to the New York Stock Exchange on March 27th! Learn more and nominate a CEO to join this invite-only event here. —
In this episode, I shares the real story behind building a sustainable hard-goods brand in the pet industry, unpacking the engineering, manufacturing, certification, and financial trade-offs that most people never see. From design constraints and material decisions to B Corp, 1% for the Planet, and sustainability reporting, this is an honest founder-level look at what it actually takes to balance environmental ambition with business reality, and why sustainability is a discipline, not a label.Timestamps to relevant points within the episode, use this format:[00:00] The Question Most Consumers Never Ask[02:10] From Sustainability Advisor to Bootstrapped Founder[04:45] Progress vs Perfection in Sustainable Business[07:30] The 4-Pillar Sustainability Framework (Environment, People, Economy, Culture)[10:15] Why Sustainability Lives in Engineering Constraints[12:00] Designing for Longevity (And the Business Model Tension)[14:20] Care-Centered Design & Piper's Physiotherapy Moment[16:30] Material Trade-Offs: Why Bamboo Wasn't the Right Choice[19:00] Certifications Explained: What Actually Matters[21:30] 1% for the Planet & Financial Accountability[23:10] FSC Packaging, REACH & Compliance[24:45] B Corp: Why It's Not a Day One Certification[26:30] Sustainability Reporting & Measurement[27:40] Why Profit Is Oxygen in Sustainable Business[29:00] Celebrating Brands That Are Doing the Work[30:00] Final Thoughts & Community InvitationLinks from the episodes:1% for the PlanetPrevious Mama Earth Talk Episode with the CEO of 1% for the Planet, Kate WilliamsPet Sustainability CoalitionB Corp CertificationForest Stewardship Council (FSC) ISO 14001 Environmental Management SystemsCradle to Cradle CertificationMama Earth Talk Online CourseKey Takeaways:• Sustainable product development is not theoretical, it's constrained by tooling costs, manufacturing realities, minimum order quantities, and cash flow.• A structured sustainability framework (Environment, People, Economy, Culture) is your decision-making filter when trade-offs get hard.• Perfection can become paralysis, progress with sequencing is often more impactful than waiting for “100% sustainable.”• Sustainability in hard goods lives in engineering decisions, not marketing language.• Designing for longevity reduces waste, but can reduce repeat purchases. That's a business model tension founders must face.• The “most sustainable-looking” material isn't always the most appropriate one. Context matters.• Certifications are validation layers, not starting point, they should align with operational readiness and financial stability.• Material compliance (FDA, REACH, BPA-free) is foundational and often more important than flashy badges.• Sustainability reporting turns intention into measurement, and measurement drives accountability.• Profit isn't the enemy of sustainability, it's oxygen. Without financial viability, environmental ambition can collapses.• Transparency builds trust when it shows process, not perfection.• Celebrating brands that are doing the structural work shifts incentives across the industry.• Sustainability isn't a label, it's an ongoing discipline.
This week's stories: Sinclair's This Is the Test: Are we about to see age reversal in humans? At the World Governments Summit 2026 in Dubai, Harvard geneticist David Sinclair told world leaders that ageing could soon be reversible and said the first human clinical trials of epigenetic reprogramming therapies are moving forward. The core idea is that ageing is partly an information problem, how cells read DNA, not just cumulative damage, and that partial reprogramming could restore youthful function without turning tissues into tumors. Dave frames this as a rare binary moment for longevity: either early, localized human trials (starting with tightly controlled tissue targets like the eye) show meaningful functional rejuvenation with acceptable safety, or the field has to recalibrate fast. Either way, the next couple of years will heavily influence where money, regulators, and serious researchers place their bets. • Sources: – World Governments Summit: https://www.worldgovernmentssummit.org/media-hub/news/detail/ageing-could-soon-be-reversible-says-harvard-scientist-at-wgs-2026 – NAD / Life Biosciences coverage: https://www.nad.com/news/fda-greenlights-life-biosciences-human-study-setting-up-pivotal-test-for-aging-theory-from-harvards-david-sinclair AlphaFold 4 in a locked box: DeepMind's private AI drug design engine Isomorphic Labs, DeepMind's drug discovery company, unveiled a proprietary drug design engine that outside scientists are comparing to an AlphaFold 4 moment, but for designing drugs, not just predicting structures. The big shift is that this system is closed: no public weights, no open database, and access appears to flow through partnerships with pharma companies. Dave breaks down why that matters for the longevity world: if AI makes early discovery cheaper and faster, we might see more serious shots on ageing targets over the next decade, but a closed model can also mean less transparency, bigger IP moats, and no guarantee that faster discovery leads to cheaper drugs. • Sources: – Nature: https://www.nature.com/articles/d41586-026-00365-7 – Isomorphic Labs: https://www.isomorphiclabs.com/articles/the-isomorphic-labs-drug-design-engine-unlocks-a-new-frontier Peptides in the freezer: El Mencho's anti aging stash and the dark side of wellness After reports and images from the final hideout linked to Jalisco New Generation Cartel leader Nemesio Oseguera Cervantes (El Mencho), coverage highlighted a detail that feels uncomfortably familiar to anyone in the modern wellness internet: injectable vials stored in a freezer with a schedule attached, including Tationil Plus, a glutathione based injectable marketed in some places for “cellular health,” cosmetic effects, and anti ageing. Dave uses the absurdity as a narrative wedge, not cartel gossip, to talk about how normalized gray market injectables have become, and how marketing (“detox,” “cellular reset”) often outruns evidence and safety. The segment pivots into a practical filter: which compounds are real therapeutics under medical supervision, and which are expensive folklore with sourcing risk and unknown long term downsides. • Sources: – New York Post: https://nypost.com/2026/02/25/world-news/inside-the-luxurious-love-nest-where-mexican-drug-lord-el-mencho-spent-his-final-days/ – Sky News (Reuters photos referenced): https://news.sky.com/story/inside-the-mexican-villa-where-feared-drug-lord-el-mencho-spent-final-hours-13511954 – Reuters photo gallery: https://www.reuters.com/pictures/el-menchos-last-hideout-inside-villa-where-cartel-leader-spent-final-hours-2026-02-25/W7DK5WEXS5IMLLZQO2P3CXGXFM The disease we thought was dead: measles comes roaring back Measles cases have surged in early 2026, with reporting citing at least 588 cases in the U.S. by late January, already more than many full year totals, and additional updates showing continued acceleration into February. Dave reframes this as a healthspan floor issue: you can argue about peptides and mitochondria all day, but measles is so contagious that once community immunity drops, outbreaks move fast and hit the most vulnerable first, especially infants and immunocompromised people. He also flags the systems problem: many clinicians have never seen measles, which increases the odds of delayed recognition and wider exposure in waiting rooms. The actionable move is boring and high ROI: verify MMR status for you and your family and close gaps before outbreaks get closer to home. • Sources: – AMA Morning Rounds (Week of Feb. 2, 2026): https://www.ama-assn.org/about/publications-newsletters/top-news-stories-ama-morning-rounds-week-feb-2-2026 – ABC News (CDC case count coverage): https://abcnews.com/Health/588-us-measles-cases-reported-january-cdc/story?id=129699078 – CIDRAP (case tracking context): https://www.cidrap.umn.edu/measles/us-measles-cases-soar-588-so-far-year-south-carolina-confirms-58-new-infections DC vs your health: Trump's State of the Union health reset President Donald Trump's 2026 State of the Union included a cluster of healthcare themes that function as a directional signal for agencies and payers this year, including drug pricing rhetoric, price transparency, and broader coverage and affordability framing. Dave translates the politics into a practical heuristic for biohackers: federal posture quietly determines what becomes easy versus painful to access in the legitimate system, from GLP 1 coverage rules and prior auth behavior to how friendly the environment is for telehealth, at home diagnostics, and eventually whatever “real longevity medicine” looks like. You do not need every policy detail in a weekly rundown, just the weather report: reimbursement and enforcement trends shape what stays niche, what scales, and what gets friction. • Sources: – Advisory Board: https://www.advisory.com/daily-briefing/2026/02/25/health-policy-roundup – Healthcare Dive: https://www.healthcaredive.com/news/trump-state-of-the-union-healthcare-2026/812962/ – This Week in Public Health analysis: https://thisweekinpublichealth.com/blog/2026/02/25/the-2026-state-of-the-union-what-it-means-for-health-and-public-health/ All source links are provided for direct access to the original reporting and research. This episode is designed for biohackers, longevity seekers, and high-performance listeners who want mechanism-level clarity on circadian biology, neurodegeneration signals, cognitive training, caffeine strategy, and supplement regulation. Host Dave Asprey connects emerging science, behavioral data, and policy shifts into practical frameworks you can use to build a resilient, adaptable health stack. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: David Sinclair age reversal, epigenetic reprogramming therapy, Yamanaka factors OSK, Life Biosciences clinical trial, human rejuvenation trial 2026, biological age reset, longevity breakthrough news, DeepMind Isomorphic Labs, AlphaFold 4 drug design, AI drug discovery engine, geroprotective drug development, peptide gray market risks, injectable glutathathione Tationil Plus, GLP-1 regulation FDA warning, wellness industry regulation, measles outbreak 2026 US, MMR vaccine status adults, vaccine trust public health, health policy 2026 State of the Union, GLP-1 access and reimbursement, telehealth longevity care, biohacking news, anti-aging research update Thank you to our sponsors! Resources: • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 - Introduction 0:30 - Story #1: David Sinclair 2026 2:13 - Story #2: Google Drug Discovery 3:48 - Story #3: El Mencho Biohacking5:30 - Story #4: Measles Outbreak 6:51 - Story #5: Trump State of the Union 8:00 - Weekly Roundup 9:10 - Closing See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Cindy Eckert, entrepreneur, investor, and the central figure in the new Paramount+ documentary The Pink Pill: Sex, Drugs & Who Has Control. The documentary film examines the decade-long, uphill battle to get the first FDA-approved medication for female libido, Addyi, approved and brought to market. Directed by Aisling Chin-Yee, the film highlights the stark contrast between the fast-tracked approval of Viagra for men and the intense, often biased scrutiny faced by advocates of "female Viagra.” Eckert fought for 10 years to bring Addyi to market, facing regulatory roadblocks and public skepticism, ultimately revealing systemic gender bias in healthcare. Reality Life with Kate Casey What to Watch List: https://katecasey.substack.com Patreon: http://www.patreon.com/katecasey Twitter: https://twitter.com/katecasey Instagram: http://www.instagram.com/katecaseyca Tik Tok: https://www.tiktok.com/@itskatecasey?lang=en Facebook Group: https://www.facebook.com/groups/113157919338245 Amazon List: https://www.amazon.com/shop/katecasey Like it to Know It: https://www.shopltk.com/explore/katecaseySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
© 2020-2026 Ivy Podcast Discovery LLC
